CHEBI ONTOLOGY - ANNOTATIONS
The Chemical Entities of Biological Interest (ChEBI) ontology is downloaded weekly from EMBL-EBI at http://www.ebi.ac.uk/chebi/ . The data is made available under the Creative Commons License (CC BY 3.0, http://creativecommons.org/licenses/by/3.0/ ). For more information see: Degtyarenko et al. (2008) ChEBI: a database and ontology for chemical entities of biological interest. Nucleic Acids Res. 36, D344–D350.
Term: obeticholic acid
Accession: CHEBI:43602
browse the term
Definition: A dihydroxy-5beta-cholanic acid that is chenodeoxycholic acid carrying an additional ethyl substituent at the 6alpha-position. A semi-synthetic bile acid which acts as a farnesoid X receptor agonist and is used for treatment of primary biliary cholangitis.
Synonyms: exact_synonym: 6alpha-ethyl-3alpha,7alpha-dihydroxy-5beta-cholan-24-oic acid
related_synonym: (3alpha,5beta,6alpha,7alpha)-6-ethyl-3,7-dihydroxycholan-24-oic acid; 6-ECDCA; 6-Ethyl-CDCA; 6-Ethylchenodeoxycholic acid; 6alpha-Ethyl-chenodeoxycholic acid; 6alpha-ethylchenodeoxycholic acid; Formula=C26H44O4; INT 747; INT747; InChI=1S/C26H44O4/c1-5-17-21-14-16(27)10-12-26(21,4)20-11-13-25(3)18(15(2)6-9-22(28)29)7-8-19(25)23(20)24(17)30/h15-21,23-24,27,30H,5-14H2,1-4H3,(H,28,29)/t15-,16-,17-,18-,19+,20+,21+,23+,24-,25-,26-/m1/s1; InChIKey=ZXERDUOLZKYMJM-ZWECCWDJSA-N; Ocaliva; SMILES=C1[C@@]2([C@]3(CC[C@]4([C@]([C@@]3([C@@H]([C@@H]([C@@]2(C[C@@H](C1)O)[H])CC)O)[H])(CC[C@@]4([C@@H](CCC(O)=O)C)[H])[H])C)[H])C
alt_id: CHEBI:132971; CHEBI:41467; CHEBI:43599; MESH:C464660
xref: CAS:459789-99-2; Drug_Central:5155; KEGG:C15636; KEGG:D09360
xref_mesh: MESH:C464660
xref: PDBeChem:CHC; PMID:22406511; PMID:23593273; PMID:24382005; PMID:24623154; PMID:25329562; PMID:25421586; PMID:25468160; PMID:25500425; PMID:25592258; PMID:25726736; PMID:25753820; PMID:25864227; PMID:26136168; PMID:26169860; PMID:26169861; PMID:26169862; PMID:26549695; PMID:26723896; PMID:26811456; PMID:26812075; PMID:27109453; PMID:27406083; PMID:27425465; PMID:27468093; PMID:27475255; Reaxys:9238543; Wikipedia:Obeticholic_acid
G
A2M
alpha-2-macroglobulin
decreases expression
EXP
obeticholic acid results in decreased expression of A2M mRNA
CTD
PMID:27939613
NCBI chr12:9,067,708...9,116,229
Ensembl chr12:9,067,664...9,116,229
G
ABCA1
ATP binding cassette subfamily A member 1
decreases expression
EXP
obeticholic acid results in decreased expression of ABCA1 mRNA
CTD
PMID:27939613
NCBI chr 9:104,781,006...104,928,155
Ensembl chr 9:104,781,006...104,928,155
G
ABCB11
ATP binding cassette subfamily B member 11
multiple interactions increases expression
EXP ISO
obeticholic acid promotes the reaction [PRMT1 protein binds to ABCB11 promoter] Obeticholic acid inhibits the reaction [ethanol decreases expression of Abcb11 protein in liver] [obeticholic acid co-treated with 1-Naphthylisothiocyanate] results in increased expression of ABCB11 protein; obeticholic acid inhibits the reaction [[triptolide co-treated with Lipopolysaccharides] results in decreased expression of ABCB11 protein]; obeticholic acid promotes the reaction [1-Naphthylisothiocyanate results in increased expression of ABCB11 mRNA]; obeticholic acid promotes the reaction [1-Naphthylisothiocyanate results in increased expression of ABCB11 protein] obeticholic acid results in increased expression of ABCB11 mRNA obeticholic acid inhibits the reaction [Isoniazid results in decreased expression of ABCB11 mRNA]; obeticholic acid inhibits the reaction [Pyrazinamide results in decreased expression of ABCB11 mRNA]
CTD RGD
PMID:15644430 PMID:15911693 PMID:27255380 PMID:27939613 PMID:29660435 PMID:32673658 PMID:36328986 PMID:36787806 PMID:27939985 More...
RGD:15036816
NCBI chr 2:168,915,390...169,031,324
Ensembl chr 2:168,915,498...169,031,324
G
ABCB4
ATP binding cassette subfamily B member 4
multiple interactions increases expression
ISO EXP
obeticholic acid inhibits the reaction [Pyrazinamide results in decreased expression of ABCB4 mRNA] obeticholic acid results in increased expression of ABCB4 mRNA
CTD
PMID:15644430 PMID:27255380 PMID:27939613
NCBI chr 7:87,365,896...87,476,027
Ensembl chr 7:87,401,696...87,480,435
G
ABCC2
ATP binding cassette subfamily C member 2
multiple interactions increases expression
ISO
obeticholic acid inhibits the reaction [Pyrazinamide results in decreased expression of ABCC2 mRNA] [obeticholic acid co-treated with 1-Naphthylisothiocyanate] results in increased expression of ABCC2 protein; [triptolide co-treated with Lipopolysaccharides co-treated with obeticholic acid] results in increased expression of ABCC2 mRNA; NR1H4 promotes the reaction [obeticholic acid promotes the reaction [1-Naphthylisothiocyanate results in increased expression of ABCC2 mRNA]]; obeticholic acid promotes the reaction [1-Naphthylisothiocyanate results in increased expression of ABCC2 mRNA]; obeticholic acid promotes the reaction [1-Naphthylisothiocyanate results in increased expression of ABCC2 protein] obeticholic acid results in increased expression of ABCC2 mRNA
CTD
PMID:15644430 PMID:27255380 PMID:29660435 PMID:36328986 PMID:36787806
NCBI chr10:99,782,640...99,852,594
Ensembl chr10:99,782,640...99,852,594
G
ABCC3
ATP binding cassette subfamily C member 3
multiple interactions
ISO
obeticholic acid inhibits the reaction [Isoniazid results in decreased expression of ABCC3 mRNA] [obeticholic acid co-treated with 1-Naphthylisothiocyanate] results in increased expression of ABCC3 protein
CTD
PMID:32673658 PMID:36787806
NCBI chr17:50,634,881...50,692,253
Ensembl chr17:50,634,777...50,692,253
G
ABCC4
ATP binding cassette subfamily C member 4 (PEL blood group)
multiple interactions
ISO
[obeticholic acid co-treated with 1-Naphthylisothiocyanate] results in increased expression of ABCC4 protein
CTD
PMID:36787806
NCBI chr13:95,019,835...95,301,451
Ensembl chr13:95,019,835...95,301,475
G
ABCG1
ATP binding cassette subfamily G member 1
decreases expression
EXP
obeticholic acid results in decreased expression of ABCG1 mRNA
CTD
PMID:27939613
NCBI chr21:42,199,689...42,297,244
Ensembl chr21:42,199,689...42,297,244
G
ACAA1
acetyl-CoA acyltransferase 1
increases expression
EXP
obeticholic acid results in increased expression of ACAA1 mRNA
CTD
PMID:27939613
NCBI chr 3:38,122,715...38,137,127
Ensembl chr 3:38,103,129...38,137,242
G
ACAA2
acetyl-CoA acyltransferase 2
increases expression
EXP
obeticholic acid results in increased expression of ACAA2 mRNA
CTD
PMID:27939613
NCBI chr18:49,782,164...49,813,533
Ensembl chr18:49,782,164...49,813,953
G
ACACA
acetyl-CoA carboxylase alpha
decreases expression
EXP
obeticholic acid results in decreased expression of ACACA mRNA
CTD
PMID:27939613
NCBI chr17:37,084,992...37,406,836
Ensembl chr17:37,084,992...37,406,836
G
ACOT9
acyl-CoA thioesterase 9
increases expression
EXP
obeticholic acid results in increased expression of ACOT9 mRNA
CTD
PMID:27939613
NCBI chr X:23,701,055...23,743,276
Ensembl chr X:23,701,055...23,766,475
G
ACOX1
acyl-CoA oxidase 1
increases expression
ISO EXP
obeticholic acid results in increased expression of ACOX1 mRNA
CTD
PMID:26655953 PMID:27939613
NCBI chr17:75,941,507...75,979,166
Ensembl chr17:75,941,507...75,979,177
G
ACOX2
acyl-CoA oxidase 2
increases expression
EXP
obeticholic acid results in increased expression of ACOX2 mRNA
CTD
PMID:27939613
NCBI chr 3:58,505,136...58,537,190
Ensembl chr 3:58,505,136...58,537,283
G
ACOX3
acyl-CoA oxidase 3, pristanoyl
increases expression
EXP
obeticholic acid results in increased expression of ACOX3 mRNA
CTD
PMID:27939613
NCBI chr 4:8,355,305...8,440,723
Ensembl chr 4:8,366,282...8,440,723
G
ACSL1
acyl-CoA synthetase long chain family member 1
decreases expression
EXP
obeticholic acid results in decreased expression of ACSL1 mRNA
CTD
PMID:27939613
NCBI chr 4:184,755,595...184,826,594
Ensembl chr 4:184,755,595...184,826,818
G
ACSL4
acyl-CoA synthetase long chain family member 4
increases expression
EXP
obeticholic acid results in increased expression of ACSL4 mRNA
CTD
PMID:27939613
NCBI chr X:109,641,335...109,733,257
Ensembl chr X:109,624,244...109,733,403
G
ACSL5
acyl-CoA synthetase long chain family member 5
increases expression
EXP
obeticholic acid results in increased expression of ACSL5 mRNA
CTD
PMID:27939613
NCBI chr10:112,374,116...112,428,376
Ensembl chr10:112,374,116...112,428,379
G
ACSL6
acyl-CoA synthetase long chain family member 6
increases expression
EXP
obeticholic acid results in increased expression of ACSL6 mRNA
CTD
PMID:27939613
NCBI chr 5:131,949,973...132,012,213
Ensembl chr 5:131,949,973...132,012,243
G
ADAMTSL2
ADAMTS like 2
decreases expression
EXP
obeticholic acid results in decreased expression of ADAMTSL2 mRNA
CTD
PMID:27939613
NCBI chr 9:133,532,164...133,575,519
Ensembl chr 9:133,532,164...133,575,519
G
ADCY1
adenylate cyclase 1
increases expression
EXP
obeticholic acid results in increased expression of ADCY1 mRNA
CTD
PMID:27939613
NCBI chr 7:45,574,140...45,723,116
Ensembl chr 7:45,574,140...45,723,116
G
ADH1C
alcohol dehydrogenase 1C (class I), gamma polypeptide
decreases expression
EXP
obeticholic acid results in decreased expression of ADH1C mRNA
CTD
PMID:27939613
NCBI chr 4:99,336,497...99,352,746
Ensembl chr 4:99,336,497...99,352,746
G
AGPAT2
1-acylglycerol-3-phosphate O-acyltransferase 2
decreases expression
EXP
obeticholic acid results in decreased expression of AGPAT2 mRNA
CTD
PMID:27939613
NCBI chr 9:136,673,143...136,687,457
Ensembl chr 9:136,673,143...136,687,457
G
AGPAT5
1-acylglycerol-3-phosphate O-acyltransferase 5
decreases expression
EXP
obeticholic acid results in decreased expression of AGPAT5 mRNA
CTD
PMID:27939613
NCBI chr 8:6,708,642...6,761,503
Ensembl chr 8:6,708,642...6,761,503
G
AKR1D1
aldo-keto reductase family 1 member D1
decreases expression
EXP
obeticholic acid results in decreased expression of AKR1D1 mRNA
CTD
PMID:27939613
NCBI chr 7:138,076,459...138,118,305
Ensembl chr 7:138,002,324...138,118,305
G
AKT1
AKT serine/threonine kinase 1
decreases expression decreases phosphorylation multiple interactions
EXP ISO
obeticholic acid results in decreased expression of AKT1 mRNA obeticholic acid results in decreased phosphorylation of AKT1 protein obeticholic acid inhibits the reaction [Carbon Tetrachloride results in increased phosphorylation of AKT1 protein]; obeticholic acid promotes the reaction [Dietary Fats results in decreased phosphorylation of AKT1 protein]
CTD
PMID:27865854 PMID:27939613 PMID:35267068
NCBI chr14:104,769,349...104,795,748
Ensembl chr14:104,769,349...104,795,759
G
AKT2
AKT serine/threonine kinase 2
decreases expression
EXP
obeticholic acid results in decreased expression of AKT2 mRNA
CTD
PMID:27939613
NCBI chr19:40,230,317...40,285,345
Ensembl chr19:40,230,317...40,285,536
G
ALB
albumin
decreases expression multiple interactions
EXP ISO
obeticholic acid results in decreased expression of ALB mRNA [Dietary Fats co-treated with obeticholic acid] results in decreased expression of ALB mRNA; [Dietary Fats co-treated with obeticholic acid] results in decreased expression of ALB protein
CTD
PMID:27939613 PMID:35267068
NCBI chr 4:73,404,287...73,421,482
Ensembl chr 4:73,397,114...73,421,482
G
ALDOA
aldolase, fructose-bisphosphate A
decreases expression
EXP
obeticholic acid results in decreased expression of ALDOA mRNA
CTD
PMID:27939613
NCBI chr16:30,064,279...30,070,420
Ensembl chr16:30,064,164...30,070,457
G
ALDOB
aldolase, fructose-bisphosphate B
decreases expression
EXP
obeticholic acid results in decreased expression of ALDOB mRNA
CTD
PMID:27939613
NCBI chr 9:101,420,560...101,435,774
Ensembl chr 9:101,420,560...101,449,664
G
ALDOC
aldolase, fructose-bisphosphate C
increases expression
EXP
obeticholic acid results in increased expression of ALDOC mRNA
CTD
PMID:27939613
NCBI chr17:28,573,120...28,576,895
Ensembl chr17:28,573,115...28,576,948
G
AMN
amnion associated transmembrane protein
decreases expression
EXP
obeticholic acid results in decreased expression of AMN mRNA
CTD
PMID:27939613
NCBI chr14:102,922,663...102,930,842
Ensembl chr14:102,922,663...102,933,596
G
AOC4P
amine oxidase copper containing 4, pseudogene
increases expression
EXP
obeticholic acid results in increased expression of AOC4P mRNA
CTD
PMID:27939613
NCBI chr17:42,867,145...42,869,217
Ensembl chr17:42,865,922...42,874,246 Ensembl chr17:42,865,922...42,874,246
G
APOA1
apolipoprotein A1
decreases expression
EXP
obeticholic acid results in decreased expression of APOA1 mRNA
CTD
PMID:27939613
NCBI chr11:116,835,751...116,837,950
Ensembl chr11:116,835,751...116,837,622
G
APOA2
apolipoprotein A2
increases expression
EXP
obeticholic acid results in increased expression of APOA2 mRNA
CTD
PMID:27939613
NCBI chr 1:161,222,292...161,223,628
Ensembl chr 1:161,222,292...161,223,631
G
APOB
apolipoprotein B
increases expression
EXP
obeticholic acid results in increased expression of APOB mRNA
CTD
PMID:27939613
NCBI chr 2:21,001,429...21,044,073
Ensembl chr 2:21,001,429...21,044,073
G
APOC2
apolipoprotein C2
increases expression
EXP
obeticholic acid results in increased expression of APOC2 mRNA
CTD
PMID:27939613
NCBI chr19:44,946,051...44,949,565
Ensembl chr19:44,946,035...44,949,565
G
APOC3
apolipoprotein C3
decreases expression
EXP
obeticholic acid results in decreased expression of APOC3 mRNA
CTD
PMID:27939613
NCBI chr11:116,829,907...116,833,072
Ensembl chr11:116,829,706...116,833,072
G
APOE
apolipoprotein E
decreases expression
EXP
obeticholic acid results in decreased expression of APOE mRNA
CTD
PMID:27939613
NCBI chr19:44,905,796...44,909,393
Ensembl chr19:44,905,791...44,909,393
G
ASPG
asparaginase
decreases expression
EXP
obeticholic acid results in decreased expression of ASPG mRNA
CTD
PMID:27939613
NCBI chr14:104,085,700...104,115,582
Ensembl chr14:104,085,686...104,115,582
G
ATG5
autophagy related 5
multiple interactions
ISO
obeticholic acid inhibits the reaction [[Dietary Fats co-treated with Dextran Sulfate] results in decreased expression of ATG5 mRNA]
CTD
PMID:35439472
NCBI chr 6:106,184,476...106,325,760
Ensembl chr 6:106,045,423...106,325,791
G
BAD
BCL2 associated agonist of cell death
decreases expression
EXP
obeticholic acid results in decreased expression of BAD mRNA
CTD
PMID:27939613
NCBI chr11:64,269,828...64,284,704
Ensembl chr11:64,269,830...64,284,704
G
BCL2
BCL2 apoptosis regulator
increases expression multiple interactions
EXP ISO
obeticholic acid results in increased expression of BCL2 mRNA [Dietary Fats co-treated with obeticholic acid] results in decreased expression of BCL2 protein
CTD
PMID:27939613 PMID:35267068
NCBI chr18:63,123,346...63,320,090
Ensembl chr18:63,123,346...63,320,128
G
BID
BH3 interacting domain death agonist
decreases expression
EXP
obeticholic acid results in decreased expression of BID mRNA
CTD
PMID:27939613
NCBI chr22:17,734,138...17,774,665
Ensembl chr22:17,734,138...17,774,770
G
BIRC3
baculoviral IAP repeat containing 3
decreases expression
EXP
obeticholic acid results in decreased expression of BIRC3 mRNA
CTD
PMID:27939613
NCBI chr11:102,317,484...102,339,403
Ensembl chr11:102,317,484...102,339,403
G
C5AR2
complement C5a receptor 2
decreases expression
EXP
obeticholic acid results in decreased expression of C5AR2 mRNA
CTD
PMID:27939613
NCBI chr19:47,332,175...47,347,329
Ensembl chr19:47,332,175...47,347,329
G
CA14
carbonic anhydrase 14
increases expression
EXP
obeticholic acid results in increased expression of CA14 mRNA
CTD
PMID:27939613
NCBI chr 1:150,257,774...150,265,078
Ensembl chr 1:150,257,251...150,265,078
G
CASP10
caspase 10
increases expression
EXP
obeticholic acid results in increased expression of CASP10 mRNA
CTD
PMID:27939613
NCBI chr 2:201,183,141...201,229,406
Ensembl chr 2:201,182,872...201,229,428
G
CASP3
caspase 3
multiple interactions
ISO
obeticholic acid promotes the reaction [Cycloheximide results in increased activity of CASP3 protein] obeticholic acid inhibits the reaction [Dietary Fats results in increased expression of CASP3 protein]
CTD
PMID:15860571 PMID:26655953
NCBI chr 4:184,627,696...184,649,447
Ensembl chr 4:184,627,696...184,650,062
G
CASP4
caspase 4
multiple interactions
ISO
obeticholic acid inhibits the reaction [[triptolide co-treated with Lipopolysaccharides] results in increased cleavage of CASP4 protein]
CTD
PMID:36328986
NCBI chr11:104,942,866...104,968,574
Ensembl chr11:104,942,866...104,969,366
G
CASP8
caspase 8
increases expression
EXP
obeticholic acid results in increased expression of CASP8 mRNA
CTD
PMID:27939613
NCBI chr 2:201,233,463...201,287,711
Ensembl chr 2:201,233,443...201,361,836
G
CCL2
C-C motif chemokine ligand 2
multiple interactions
ISO
obeticholic acid inhibits the reaction [Carbon Tetrachloride results in increased expression of CCL2 mRNA]
CTD
PMID:27865854
NCBI chr17:34,255,285...34,257,203
Ensembl chr17:34,255,274...34,257,208
G
CCNB1
cyclin B1
multiple interactions
ISO
obeticholic acid promotes the reaction [1-Naphthylisothiocyanate results in increased expression of CCNB1 protein]
CTD
PMID:29660435
NCBI chr 5:69,167,150...69,178,245
Ensembl chr 5:69,167,135...69,178,245
G
CCND1
cyclin D1
multiple interactions
ISO
obeticholic acid inhibits the reaction [[Dietary Fats co-treated with Dextran Sulfate] results in decreased expression of CCND1 protein]; obeticholic acid promotes the reaction [1-Naphthylisothiocyanate results in increased expression of CCND1 protein]
CTD
PMID:29660435 PMID:35439472
NCBI chr11:69,641,156...69,654,474
Ensembl chr11:69,641,156...69,654,474
G
CCS
copper chaperone for superoxide dismutase
decreases expression
EXP
obeticholic acid results in decreased expression of CCS mRNA
CTD
PMID:27939613
NCBI chr11:66,593,185...66,606,019
Ensembl chr11:66,593,153...66,606,019
G
CD14
CD14 molecule
decreases expression
EXP
obeticholic acid results in decreased expression of CD14 mRNA
CTD
PMID:27939613
NCBI chr 5:140,631,732...140,633,701
Ensembl chr 5:140,631,728...140,633,700
G
CLDN5
claudin 5
multiple interactions
ISO
obeticholic acid inhibits the reaction [Methamphetamine results in decreased expression of CLDN5 protein]
CTD
PMID:36720452
NCBI chr22:19,523,024...19,525,337
Ensembl chr22:19,523,024...19,527,545
G
CLIC4
chloride intracellular channel 4
increases expression
EXP
obeticholic acid results in increased expression of CLIC4 mRNA
CTD
PMID:27939613
NCBI chr 1:24,745,447...24,844,321
Ensembl chr 1:24,745,382...24,844,321
G
COL1A1
collagen type I alpha 1 chain
decreases expression multiple interactions
ISO EXP
obeticholic acid results in decreased expression of COL1A1 mRNA; obeticholic acid results in decreased expression of COL1A1 protein obeticholic acid inhibits the reaction [[Methionine deficiency co-treated with Choline deficiency] results in increased expression of COL1A1 mRNA] obeticholic acid inhibits the reaction [TGFB1 protein results in increased expression of COL1A1 mRNA]
CTD
PMID:15860571 PMID:15980055 PMID:27939613 PMID:30745416
NCBI chr17:50,184,101...50,201,631
Ensembl chr17:50,184,101...50,201,632
G
CPT1A
carnitine palmitoyltransferase 1A
multiple interactions increases expression
ISO EXP
obeticholic acid promotes the reaction [Palmitic Acid results in increased expression of CPT1A mRNA] obeticholic acid results in increased expression of CPT1A protein Obeticholic acid inhibits the reaction [ethanol decreases expression of CPT1a mRNA and protein in liver] obeticholic acid inhibits the reaction [Ethanol results in decreased expression of CPT1A protein] obeticholic acid results in increased expression of CPT1A mRNA
CTD RGD
PMID:26655953 PMID:27939613 PMID:27939985 PMID:32738331 PMID:27939985
RGD:15036816
NCBI chr11:68,754,620...68,844,277
Ensembl chr11:68,754,620...68,844,410
G
CPT2
carnitine palmitoyltransferase 2
increases expression
EXP
obeticholic acid results in increased expression of CPT2 mRNA
CTD
PMID:27939613
NCBI chr 1:53,196,824...53,214,197
Ensembl chr 1:53,196,792...53,214,197
G
CRCT1
cysteine rich C-terminal 1
decreases expression
EXP
obeticholic acid results in decreased expression of CRCT1 mRNA
CTD
PMID:27939613
NCBI chr 1:152,514,482...152,516,008
Ensembl chr 1:152,514,482...152,516,008
G
CREB3L1
cAMP responsive element binding protein 3 like 1
decreases expression
EXP
obeticholic acid results in decreased expression of CREB3L1 mRNA
CTD
PMID:27939613
NCBI chr11:46,277,662...46,321,409
Ensembl chr11:46,277,662...46,321,409
G
CREB3L3
cAMP responsive element binding protein 3 like 3
increases expression
EXP
obeticholic acid results in increased expression of CREB3L3 mRNA
CTD
PMID:27939613
NCBI chr19:4,153,631...4,173,054
Ensembl chr19:4,153,631...4,173,054
G
CRP
C-reactive protein
decreases expression
EXP
obeticholic acid results in decreased expression of CRP mRNA
CTD
PMID:27939613
NCBI chr 1:159,712,289...159,714,589
Ensembl chr 1:159,712,289...159,714,589
G
CTAGE15
CTAGE family member 15
increases expression
EXP
obeticholic acid results in increased expression of CTAGE15 mRNA
CTD
PMID:27939613
NCBI chr 7:143,571,801...143,574,387
Ensembl chr 7:143,571,801...143,574,387
G
CXCL1
C-X-C motif chemokine ligand 1
multiple interactions
ISO
obeticholic acid inhibits the reaction [Carbon Tetrachloride results in increased expression of CXCL1 mRNA]
CTD
PMID:27865854
NCBI chr 4:73,869,393...73,871,308
Ensembl chr 4:73,869,393...73,871,308
G
CXCL2
C-X-C motif chemokine ligand 2
multiple interactions
ISO
obeticholic acid inhibits the reaction [Carbon Tetrachloride results in increased expression of CXCL2 mRNA]
CTD
PMID:27865854
NCBI chr 4:74,097,040...74,099,195
Ensembl chr 4:74,097,040...74,099,196
G
CYP19A1
cytochrome P450 family 19 subfamily A member 1
decreases expression
EXP
obeticholic acid results in decreased expression of CYP19A1 mRNA
CTD
PMID:27939613
NCBI chr15:51,208,057...51,338,596
Ensembl chr15:51,208,057...51,338,601
G
CYP1A1
cytochrome P450 family 1 subfamily A member 1
decreases expression
EXP
obeticholic acid results in decreased expression of CYP1A1 mRNA
CTD
PMID:27939613
NCBI chr15:74,719,542...74,725,528
Ensembl chr15:74,719,542...74,725,536
G
CYP1A2
cytochrome P450 family 1 subfamily A member 2
decreases expression multiple interactions decreases activity
EXP ISO
obeticholic acid results in decreased expression of CYP1A2 mRNA [Dietary Fats co-treated with obeticholic acid] results in decreased expression of CYP1A2 mRNA; [Dietary Fats co-treated with obeticholic acid] results in decreased expression of CYP1A2 protein obeticholic acid results in decreased activity of CYP1A2 protein obeticholic acid inhibits the reaction [CYP1A2 protein results in increased chemical synthesis of Acetaminophen]; obeticholic acid inhibits the reaction [CYP1A2 protein results in increased metabolism of Phenacetin]
CTD
PMID:27939613 PMID:35267068
NCBI chr15:74,748,845...74,756,607
Ensembl chr15:74,748,845...74,756,607
G
CYP21A2
cytochrome P450 family 21 subfamily A member 2
decreases expression
EXP
obeticholic acid results in decreased expression of CYP21A2 mRNA
CTD
PMID:27939613
NCBI chr 6:32,038,415...32,041,644
Ensembl chr 6:32,038,327...32,041,644
G
CYP27A1
cytochrome P450 family 27 subfamily A member 1
decreases expression
EXP
obeticholic acid results in decreased expression of CYP27A1 mRNA
CTD
PMID:27939613
NCBI chr 2:218,782,147...218,815,293
Ensembl chr 2:218,781,749...218,815,293
G
CYP2A6
cytochrome P450 family 2 subfamily A member 6
increases expression
EXP
obeticholic acid results in increased expression of CYP2A6 mRNA
CTD
PMID:27939613
NCBI chr19:40,843,541...40,850,447
Ensembl chr19:40,843,541...40,850,447
G
CYP2C8
cytochrome P450 family 2 subfamily C member 8
decreases expression
EXP
obeticholic acid results in decreased expression of CYP2C8 mRNA
CTD
PMID:27939613
NCBI chr10:95,036,772...95,069,497
Ensembl chr10:95,036,772...95,069,497
G
CYP2C9
cytochrome P450 family 2 subfamily C member 9
decreases expression
EXP
obeticholic acid results in decreased expression of CYP2C9 mRNA
CTD
PMID:27939613
NCBI chr10:94,938,658...94,990,091
Ensembl chr10:94,938,658...94,990,091
G
CYP2D6
cytochrome P450 family 2 subfamily D member 6
increases expression
EXP
obeticholic acid results in increased expression of CYP2D6 mRNA
CTD
PMID:27939613
NCBI chr22:42,126,499...42,130,810
Ensembl chr22:42,126,499...42,130,865
G
CYP2E1
cytochrome P450 family 2 subfamily E member 1
decreases expression
EXP
obeticholic acid results in decreased expression of CYP2E1 mRNA
CTD
PMID:27939613
NCBI chr10:133,527,363...133,539,123
Ensembl chr10:133,520,406...133,561,220
G
CYP2R1
cytochrome P450 family 2 subfamily R member 1
increases expression
EXP
obeticholic acid results in increased expression of CYP2R1 mRNA
CTD
PMID:27939613
NCBI chr11:14,877,440...14,892,443
Ensembl chr11:14,877,440...14,892,231
G
CYP2S1
cytochrome P450 family 2 subfamily S member 1
decreases expression
EXP
obeticholic acid results in decreased expression of CYP2S1 mRNA
CTD
PMID:27939613
NCBI chr19:41,193,219...41,207,539
Ensembl chr19:41,193,210...41,207,539
G
CYP2U1
cytochrome P450 family 2 subfamily U member 1
increases expression
EXP
obeticholic acid results in increased expression of CYP2U1 mRNA
CTD
PMID:27939613
NCBI chr 4:107,931,549...107,953,461
Ensembl chr 4:107,931,549...107,953,461
G
CYP39A1
cytochrome P450 family 39 subfamily A member 1
decreases expression
EXP
obeticholic acid results in decreased expression of CYP39A1 mRNA
CTD
PMID:27939613
NCBI chr 6:46,549,580...46,652,818
Ensembl chr 6:46,549,580...46,652,830
G
CYP3A4
cytochrome P450 family 3 subfamily A member 4
decreases activity decreases expression multiple interactions
EXP ISO
obeticholic acid results in decreased activity of CYP3A4 protein obeticholic acid results in decreased expression of CYP3A2 mRNA obeticholic acid results in decreased expression of CYP3A4 mRNA obeticholic acid inhibits the reaction [CYP3A4 protein results in increased chemical synthesis of 6 beta-hydroxytestosterone]; obeticholic acid inhibits the reaction [CYP3A4 protein results in increased metabolism of Testosterone]
CTD
PMID:27939613 PMID:35267068
NCBI chr 7:99,756,967...99,784,184
Ensembl chr 7:99,756,960...99,784,248
G
CYP3A43
cytochrome P450 family 3 subfamily A member 43
decreases expression
EXP
obeticholic acid results in decreased expression of CYP3A43 mRNA
CTD
PMID:27939613
NCBI chr 7:99,828,013...99,866,093
Ensembl chr 7:99,828,013...99,866,093
G
CYP3A5
cytochrome P450 family 3 subfamily A member 5
decreases expression
EXP
obeticholic acid results in decreased expression of CYP3A5 mRNA
CTD
PMID:27939613
NCBI chr 7:99,648,194...99,679,996
Ensembl chr 7:99,648,194...99,679,996
G
CYP3A7
cytochrome P450 family 3 subfamily A member 7
decreases expression
EXP
obeticholic acid results in decreased expression of CYP3A7 mRNA
CTD
PMID:27939613
NCBI chr 7:99,705,036...99,735,196
Ensembl chr 7:99,705,036...99,735,196
G
CYP4A11
cytochrome P450 family 4 subfamily A member 11
increases expression
EXP
obeticholic acid results in increased expression of CYP4A11 mRNA
CTD
PMID:27939613
NCBI chr 1:46,929,188...46,941,476
Ensembl chr 1:46,929,177...46,941,484
G
CYP4F11
cytochrome P450 family 4 subfamily F member 11
decreases expression
EXP
obeticholic acid results in decreased expression of CYP4F11 mRNA
CTD
PMID:27939613
NCBI chr19:15,912,377...15,934,867
Ensembl chr19:15,912,367...15,934,867
G
CYP4F12
cytochrome P450 family 4 subfamily F member 12
decreases expression
EXP
obeticholic acid results in decreased expression of CYP4F12 mRNA
CTD
PMID:27939613
NCBI chr19:15,673,087...15,697,174
Ensembl chr19:15,673,018...15,697,174
G
CYP4F22
cytochrome P450 family 4 subfamily F member 22
decreases expression
EXP
obeticholic acid results in decreased expression of CYP4F22 mRNA
CTD
PMID:27939613
NCBI chr19:15,508,525...15,552,317
Ensembl chr19:15,508,525...15,552,317
G
CYP4F3
cytochrome P450 family 4 subfamily F member 3
decreases expression
EXP
obeticholic acid results in decreased expression of CYP4F3 mRNA
CTD
PMID:27939613
NCBI chr19:15,640,897...15,662,825
Ensembl chr19:15,640,897...15,662,825
G
CYP51A1
cytochrome P450 family 51 subfamily A member 1
decreases expression
EXP
obeticholic acid results in decreased expression of CYP51A1 mRNA
CTD
PMID:27939613
NCBI chr 7:92,112,153...92,134,803
Ensembl chr 7:92,084,987...92,134,803
G
CYP7A1
cytochrome P450 family 7 subfamily A member 1
decreases expression multiple interactions
EXP ISO
obeticholic acid results in decreased expression of CYP7A1 mRNA obeticholic acid inhibits the reaction [Isoniazid results in increased expression of CYP7A1 mRNA] Obeticholic acid inhibits the reaction [ethanol increases expression of Cyp7a1 protein in liver] obeticholic acid decreases expression of CYP7a1 mRNA in liver in porcine serum induced model of cirrhosis in rat obeticholic acid inhibits the reaction [1-Naphthylisothiocyanate results in increased expression of CYP7A1 protein]; obeticholic acid inhibits the reaction [[triptolide co-treated with Lipopolysaccharides] results in decreased expression of CYP7A1 protein]; obeticholic acid promotes the reaction [1-Naphthylisothiocyanate results in decreased expression of CYP7A1 mRNA]
CTD RGD
PMID:15644430 PMID:15911693 PMID:27939613 PMID:29660435 PMID:32673658 PMID:35267068 PMID:36328986 PMID:36787806 PMID:27939985 PMID:15521018 More...
RGD:15036816 , RGD:15045602
NCBI chr 8:58,490,178...58,500,163
Ensembl chr 8:58,490,178...58,500,163
G
CYP8B1
cytochrome P450 family 8 subfamily B member 1
decreases expression multiple interactions increases expression
ISO EXP
obeticholic acid results in decreased expression of CYP8B1 mRNA obeticholic acid inhibits the reaction [1-Naphthylisothiocyanate results in decreased expression of CYP8B1 mRNA] obeticholic acid results in increased expression of CYP8B1 mRNA
CTD
PMID:15644430 PMID:27939613 PMID:29660435
NCBI chr 3:42,872,192...42,875,879
Ensembl chr 3:42,856,005...42,875,898
G
DDIT3
DNA damage inducible transcript 3
multiple interactions
ISO
obeticholic acid inhibits the reaction [Dietary Fats results in increased expression of DDIT3 protein]
CTD
PMID:26655953
NCBI chr12:57,516,588...57,520,517
Ensembl chr12:57,516,588...57,521,737
G
DGAT2
diacylglycerol O-acyltransferase 2
decreases expression
EXP
obeticholic acid results in decreased expression of DGAT2 mRNA
CTD
PMID:27939613
NCBI chr11:75,768,778...75,801,534
Ensembl chr11:75,759,512...75,801,535
G
DHCR7
7-dehydrocholesterol reductase
increases expression
EXP
obeticholic acid results in increased expression of DHCR7 mRNA
CTD
PMID:27939613
NCBI chr11:71,434,411...71,448,393
Ensembl chr11:71,428,193...71,452,868
G
DNAJB11
DnaJ heat shock protein family (Hsp40) member B11
increases expression
EXP
obeticholic acid results in increased expression of DNAJB11 mRNA
CTD
PMID:27939613
NCBI chr 3:186,570,720...186,585,793
Ensembl chr 3:186,567,403...186,585,800
G
DPYD
dihydropyrimidine dehydrogenase
decreases expression
EXP
obeticholic acid results in decreased expression of DPYD mRNA
CTD
PMID:27939613
NCBI chr 1:97,077,743...97,921,059
Ensembl chr 1:97,077,743...97,995,000
G
DUSP6
dual specificity phosphatase 6
increases expression
EXP
obeticholic acid results in increased expression of DUSP6 mRNA
CTD
PMID:27939613
NCBI chr12:89,347,235...89,352,501
Ensembl chr12:89,347,235...89,352,501
G
ECSIT
ECSIT signaling integrator
decreases expression
EXP
obeticholic acid results in decreased expression of ECSIT mRNA
CTD
PMID:27939613
NCBI chr19:11,505,929...11,529,134
Ensembl chr19:11,505,929...11,529,172
G
ELOVL1
ELOVL fatty acid elongase 1
increases expression
EXP
obeticholic acid results in increased expression of ELOVL1 mRNA
CTD
PMID:27939613
NCBI chr 1:43,363,401...43,368,011
Ensembl chr 1:43,363,398...43,368,074
G
ELOVL2
ELOVL fatty acid elongase 2
increases expression
EXP
obeticholic acid results in increased expression of ELOVL2 mRNA
CTD
PMID:27939613
NCBI chr 6:10,980,759...11,044,305
Ensembl chr 6:10,980,759...11,044,305
G
ELOVL6
ELOVL fatty acid elongase 6
decreases expression
EXP
obeticholic acid results in decreased expression of ELOVL6 mRNA
CTD
PMID:27939613
NCBI chr 4:110,045,846...110,199,202
Ensembl chr 4:110,045,846...110,199,199
G
ELOVL7
ELOVL fatty acid elongase 7
increases expression
EXP
obeticholic acid results in increased expression of ELOVL7 mRNA
CTD
PMID:27939613
NCBI chr 5:60,751,791...60,844,269
Ensembl chr 5:60,751,791...60,844,274
G
ENC1
ectodermal-neural cortex 1
increases expression
EXP
obeticholic acid results in increased expression of ENC1 mRNA
CTD
PMID:27939613
NCBI chr 5:74,627,409...74,640,728
Ensembl chr 5:74,627,406...74,641,424
G
ENO1
enolase 1
decreases expression
EXP
obeticholic acid results in decreased expression of ENO1 mRNA
CTD
PMID:27939613
NCBI chr 1:8,861,000...8,878,686
Ensembl chr 1:8,861,000...8,879,190
G
ENO3
enolase 3
increases expression
EXP
obeticholic acid results in increased expression of ENO3 mRNA
CTD
PMID:27939613
NCBI chr17:4,948,710...4,957,129
Ensembl chr17:4,948,092...4,957,131
G
FABP6
fatty acid binding protein 6
multiple interactions increases expression
ISO
NR1H4 gene mutant form inhibits the reaction [obeticholic acid results in increased expression of FABP6 mRNA]
CTD
PMID:22918042
NCBI chr 5:160,187,381...160,238,722
Ensembl chr 5:160,187,367...160,238,735
G
FADD
Fas associated via death domain
increases expression
EXP
obeticholic acid results in increased expression of FADD mRNA
CTD
PMID:27939613
NCBI chr11:70,203,296...70,207,390
Ensembl chr11:70,203,296...70,207,390
G
FAS
Fas cell surface death receptor
multiple interactions
ISO
Obeticholic acid inhibits the reaction [ethanol increases expression of Fas mRNA and protein in liver]
RGD
PMID:27939985
RGD:15036816
NCBI chr10:88,964,050...89,017,059
Ensembl chr10:88,953,813...89,029,605
G
FASN
fatty acid synthase
multiple interactions decreases expression
ISO EXP
obeticholic acid inhibits the reaction [Palmitic Acid results in increased expression of FASN mRNA] obeticholic acid inhibits the reaction [Ethanol results in increased expression of FASN protein] obeticholic acid results in decreased expression of FASN mRNA
CTD
PMID:26655953 PMID:27939613 PMID:27939985
NCBI chr17:82,078,338...82,098,236
Ensembl chr17:82,078,338...82,098,294
G
FBP1
fructose-bisphosphatase 1
decreases expression
EXP
obeticholic acid results in decreased expression of FBP1 mRNA
CTD
PMID:27939613
NCBI chr 9:94,603,133...94,640,263
Ensembl chr 9:94,603,133...94,640,249
G
FDPS
farnesyl diphosphate synthase
decreases expression
EXP
obeticholic acid results in decreased expression of FDPS mRNA
CTD
PMID:27939613
NCBI chr 1:155,308,866...155,320,665
Ensembl chr 1:155,308,748...155,320,666
G
FETUB
fetuin B
increases expression
EXP
obeticholic acid results in increased expression of FETUB mRNA
CTD
PMID:27939613
NCBI chr 3:186,635,969...186,653,141
Ensembl chr 3:186,635,969...186,653,141
G
FGF19
fibroblast growth factor 19
increases expression multiple interactions increases secretion
ISO EXP
obeticholic acid results in increased expression of FGF15 mRNA Obeticholic acid inhibits the reaction [ethanol decreases expression of FGF19 protein in liver and intestine] obeticholic acid results in increased expression of FGF19 mRNA obeticholic acid results in increased secretion of FGF19 protein NR1H4 gene mutant form inhibits the reaction [obeticholic acid results in increased expression of FGF15 mRNA]
CTD RGD
PMID:22918042 PMID:27939613 PMID:27939985
RGD:15036816
NCBI chr11:69,698,238...69,704,022
Ensembl chr11:69,698,238...69,704,022
G
FGFR4
fibroblast growth factor receptor 4
decreases expression
EXP
obeticholic acid results in decreased expression of FGFR4 mRNA
CTD
PMID:27939613
NCBI chr 5:177,086,915...177,098,144
Ensembl chr 5:177,086,905...177,098,144
G
FN1
fibronectin 1
decreases expression
ISO
obeticholic acid decreases expression of fibronectin mRNA in liver in porcine serum induced model of cirrhosis in rat
RGD
PMID:15980055
RGD:1625201
NCBI chr 2:215,360,865...215,436,068
Ensembl chr 2:215,360,440...215,436,073
G
FOS
Fos proto-oncogene, AP-1 transcription factor subunit
decreases expression
EXP
obeticholic acid results in decreased expression of FOS mRNA
CTD
PMID:27939613
NCBI chr14:75,278,828...75,282,230
Ensembl chr14:75,278,826...75,282,230
G
FOXM1
forkhead box M1
multiple interactions increases expression
ISO
NR1H4 affects the reaction [obeticholic acid results in increased expression of FOXM1 mRNA]; obeticholic acid promotes the reaction [1-Naphthylisothiocyanate results in increased expression of FOXM1 protein]
CTD
PMID:22135065 PMID:29660435
NCBI chr12:2,857,680...2,877,174
Ensembl chr12:2,857,680...2,877,174
G
FOXP3
forkhead box P3
increases expression
EXP
obeticholic acid results in increased expression of FOXP3 mRNA
CTD
PMID:27939613
NCBI chr X:49,250,438...49,264,710
Ensembl chr X:49,250,438...49,264,800
G
GAPDH
glyceraldehyde-3-phosphate dehydrogenase
decreases expression
EXP
obeticholic acid results in decreased expression of GAPDH mRNA
CTD
PMID:27939613
NCBI chr12:6,534,517...6,538,371
Ensembl chr12:6,534,512...6,538,374
G
GCLM
glutamate-cysteine ligase modifier subunit
increases expression
ISO
obeticholic acid results in increased expression of GCLM mRNA
CTD
PMID:26655953
NCBI chr 1:93,885,199...93,909,430
Ensembl chr 1:93,885,199...93,909,456
G
GFER
growth factor, augmenter of liver regeneration
multiple interactions
ISO
[Dietary Fats co-treated with obeticholic acid] results in decreased expression of GFER mRNA; [Dietary Fats co-treated with obeticholic acid] results in decreased expression of GFER protein
CTD
PMID:35267068
NCBI chr16:1,984,193...1,987,749
Ensembl chr16:1,984,193...1,987,749
G
GK
glycerol kinase
decreases expression
EXP
obeticholic acid results in decreased expression of GK mRNA
CTD
PMID:27939613
NCBI chr X:30,653,423...30,731,462
Ensembl chr X:30,653,359...30,731,462
G
GPAM
glycerol-3-phosphate acyltransferase, mitochondrial
decreases expression
EXP
obeticholic acid results in decreased expression of GPAM mRNA
CTD
PMID:27939613
NCBI chr10:112,149,865...112,227,677
Ensembl chr10:112,149,865...112,215,377
G
GPD1
glycerol-3-phosphate dehydrogenase 1
decreases expression
EXP
obeticholic acid results in decreased expression of GPD1 mRNA
CTD
PMID:27939613
NCBI chr12:50,104,008...50,111,313
Ensembl chr12:50,103,982...50,111,313
G
GPT
glutamic--pyruvic transaminase
multiple interactions
ISO
obeticholic acid inhibits the reaction [1-Naphthylisothiocyanate results in increased expression of GPT protein]; obeticholic acid inhibits the reaction [[triptolide co-treated with Lipopolysaccharides] results in increased expression of GPT protein]; obeticholic acid promotes the reaction [1-Naphthylisothiocyanate results in increased activity of GPT protein]; obeticholic acid promotes the reaction [Dietary Fats results in increased expression of GPT protein]
CTD
PMID:35267068 PMID:36328986 PMID:36581201 PMID:36787806
NCBI chr 8:144,503,068...144,507,172
Ensembl chr 8:144,502,973...144,507,174
G
GPX1
glutathione peroxidase 1
increases expression
ISO
obeticholic acid results in increased expression of GPX1 mRNA
CTD
PMID:26655953
NCBI chr 3:49,357,176...49,358,353
Ensembl chr 3:49,357,174...49,358,605
G
GPX2
glutathione peroxidase 2
decreases expression
EXP
obeticholic acid results in decreased expression of GPX2 mRNA
CTD
PMID:27939613
NCBI chr14:64,939,158...64,942,745
Ensembl chr14:64,939,152...64,942,746
G
GPX3
glutathione peroxidase 3
increases expression
EXP
obeticholic acid results in increased expression of GPX3 mRNA
CTD
PMID:27939613
NCBI chr 5:151,020,591...151,028,988
Ensembl chr 5:151,020,591...151,028,988
G
GSDMD
gasdermin D
multiple interactions
ISO
obeticholic acid inhibits the reaction [[triptolide co-treated with Lipopolysaccharides] results in increased cleavage of GSDMD protein]
CTD
PMID:36328986
NCBI chr 8:143,553,387...143,563,062
Ensembl chr 8:143,553,207...143,563,062
G
GSR
glutathione-disulfide reductase
increases expression
ISO EXP
obeticholic acid results in increased expression of GSR mRNA
CTD
PMID:26655953 PMID:27939613
NCBI chr 8:30,678,066...30,727,846
Ensembl chr 8:30,678,066...30,727,846
G
GSTP1
glutathione S-transferase pi 1
decreases expression
EXP
obeticholic acid results in decreased expression of GSTP1 mRNA
CTD
PMID:27939613
NCBI chr11:67,583,812...67,586,653
Ensembl chr11:67,583,742...67,586,656
G
GSTT1
glutathione S-transferase theta 1
increases expression
EXP
obeticholic acid results in increased expression of GSTT1 mRNA
CTD
PMID:27939613
G
GYS2
glycogen synthase 2
increases expression
EXP
obeticholic acid results in increased expression of GYS2 mRNA
CTD
PMID:27939613
NCBI chr12:21,532,577...21,604,847
Ensembl chr12:21,536,107...21,604,847
G
H2BC11
H2B clustered histone 11
decreases expression
EXP
obeticholic acid results in decreased expression of H2BC11 mRNA
CTD
PMID:27939613
NCBI chr 6:27,132,316...27,132,795
Ensembl chr 6:27,125,897...27,132,795
G
HMGCR
3-hydroxy-3-methylglutaryl-CoA reductase
decreases expression
EXP
obeticholic acid results in decreased expression of HMGCR mRNA
CTD
PMID:27939613
NCBI chr 5:75,336,529...75,362,116
Ensembl chr 5:75,336,329...75,364,001
G
HMGCS1
3-hydroxy-3-methylglutaryl-CoA synthase 1
decreases expression
EXP
obeticholic acid results in decreased expression of HMGCS1 mRNA
CTD
PMID:27939613
NCBI chr 5:43,287,470...43,313,412
Ensembl chr 5:43,287,470...43,313,512
G
HNF4A
hepatocyte nuclear factor 4 alpha
multiple interactions decreases expression
ISO
[Dietary Fats co-treated with obeticholic acid] results in decreased expression of HNF4A mRNA; [Dietary Fats co-treated with obeticholic acid] results in decreased expression of HNF4A protein obeticholic acid results in decreased expression of HNF4A mRNA
CTD
PMID:35267068
NCBI chr20:44,355,699...44,434,596
Ensembl chr20:44,355,699...44,432,845
G
HRAS
HRas proto-oncogene, GTPase
decreases expression
EXP
obeticholic acid results in decreased expression of HRAS mRNA
CTD
PMID:27939613
NCBI chr11:532,242...535,576
Ensembl chr11:532,242...537,321
G
HSD17B7
hydroxysteroid 17-beta dehydrogenase 7
decreases expression
EXP
obeticholic acid results in decreased expression of HSD17B7 mRNA
CTD
PMID:27939613
NCBI chr 1:162,790,702...162,812,823
Ensembl chr 1:162,790,702...162,812,823
G
HSD3B7
hydroxy-delta-5-steroid dehydrogenase, 3 beta- and steroid delta-isomerase 7
decreases expression
EXP
obeticholic acid results in decreased expression of HSD3B7 mRNA
CTD
PMID:27939613
NCBI chr16:30,985,207...30,989,147
Ensembl chr16:30,985,207...30,989,147
G
HSPA5
heat shock protein family A (Hsp70) member 5
multiple interactions
ISO
obeticholic acid inhibits the reaction [Dietary Fats results in increased expression of HSPA5 protein]; obeticholic acid inhibits the reaction [Palmitic Acid results in increased expression of HSPA5 protein]
CTD
PMID:26655953
NCBI chr 9:125,234,853...125,241,343
Ensembl chr 9:125,234,853...125,241,382
G
HSPG2
heparan sulfate proteoglycan 2
decreases expression
EXP
obeticholic acid results in decreased expression of HSPG2 mRNA
CTD
PMID:27939613
NCBI chr 1:21,822,244...21,937,310
Ensembl chr 1:21,822,244...21,937,310
G
ID2
inhibitor of DNA binding 2
decreases expression
EXP
obeticholic acid results in decreased expression of ID2 mRNA
CTD
PMID:27939613
NCBI chr 2:8,682,056...8,684,461
Ensembl chr 2:8,678,845...8,684,461
G
IDI1
isopentenyl-diphosphate delta isomerase 1
decreases expression
EXP
obeticholic acid results in decreased expression of IDI1 mRNA
CTD
PMID:27939613
NCBI chr10:1,039,152...1,056,704
Ensembl chr10:1,039,152...1,049,119
G
IGFALS
insulin like growth factor binding protein acid labile subunit
decreases expression
EXP
obeticholic acid results in decreased expression of IGFALS mRNA
CTD
PMID:27939613
NCBI chr16:1,790,413...1,794,908
Ensembl chr16:1,790,413...1,794,971
G
IL10
interleukin 10
multiple interactions
ISO
obeticholic acid inhibits the reaction [[Methionine deficiency co-treated with Choline deficiency] results in increased expression of IL10 protein]; obeticholic acid inhibits the reaction [Dietary Fats results in increased expression of IL10 protein]
CTD
PMID:30745416
NCBI chr 1:206,767,602...206,772,494
Ensembl chr 1:206,767,602...206,774,541
G
IL18
interleukin 18
multiple interactions
ISO
obeticholic acid inhibits the reaction [Methamphetamine results in increased expression of IL18 mRNA]
CTD
PMID:35688268
NCBI chr11:112,143,260...112,164,094
Ensembl chr11:112,143,253...112,164,096
G
IL1B
interleukin 1 beta
multiple interactions
ISO
obeticholic acid inhibits the reaction [1-Naphthylisothiocyanate results in increased expression of IL1B mRNA]; obeticholic acid inhibits the reaction [Carbon Tetrachloride results in increased expression of IL1B mRNA]; obeticholic acid inhibits the reaction [Dietary Fats results in increased expression of IL1B protein]; obeticholic acid inhibits the reaction [Methamphetamine results in increased expression of IL1B mRNA]
CTD
PMID:27865854 PMID:29660435 PMID:35688268 PMID:38103844
NCBI chr 2:112,829,751...112,836,779
Ensembl chr 2:112,829,751...112,836,816
G
IL4
interleukin 4
multiple interactions
ISO
obeticholic acid promotes the reaction [Carbon Tetrachloride results in increased expression of IL4 mRNA]
CTD
PMID:27865854
NCBI chr 5:132,673,989...132,682,678
Ensembl chr 5:132,673,986...132,682,678
G
IL6
interleukin 6
multiple interactions
ISO
obeticholic acid inhibits the reaction [1-Naphthylisothiocyanate results in increased expression of IL6 mRNA]; obeticholic acid inhibits the reaction [[Methionine deficiency co-treated with Choline deficiency] results in increased expression of IL6 protein]; obeticholic acid inhibits the reaction [Dietary Fats results in increased expression of IL6 protein]; obeticholic acid inhibits the reaction [Methamphetamine results in increased expression of IL6 mRNA]
CTD
PMID:29660435 PMID:30745416 PMID:35688268 PMID:36720452 PMID:38103844
NCBI chr 7:22,727,200...22,731,998
Ensembl chr 7:22,725,884...22,732,002
G
IL6R
interleukin 6 receptor
decreases expression
EXP
obeticholic acid results in decreased expression of IL6R mRNA
CTD
PMID:27939613
NCBI chr 1:154,405,343...154,469,450
Ensembl chr 1:154,405,193...154,469,450
G
IL6ST
interleukin 6 cytokine family signal transducer
decreases expression
EXP
obeticholic acid results in decreased expression of IL6ST mRNA
CTD
PMID:27939613
NCBI chr 5:55,935,095...55,994,963
Ensembl chr 5:55,935,095...55,995,022
G
INHBB
inhibin subunit beta B
increases expression
EXP
obeticholic acid results in increased expression of INHBB mRNA
CTD
PMID:27939613
NCBI chr 2:120,346,136...120,351,803
Ensembl chr 2:120,346,136...120,351,803
G
IRAK1
interleukin 1 receptor associated kinase 1
decreases expression
EXP
obeticholic acid results in decreased expression of IRAK1 mRNA
CTD
PMID:27939613
NCBI chr X:154,010,507...154,019,902
Ensembl chr X:154,010,506...154,019,902
G
IRAK2
interleukin 1 receptor associated kinase 2
decreases expression
EXP
obeticholic acid results in decreased expression of IRAK2 mRNA
CTD
PMID:27939613
NCBI chr 3:10,164,919...10,243,745
Ensembl chr 3:10,164,919...10,243,745
G
JUN
Jun proto-oncogene, AP-1 transcription factor subunit
increases expression
EXP
obeticholic acid results in increased expression of JUN mRNA
CTD
PMID:27939613
NCBI chr 1:58,780,791...58,784,047
Ensembl chr 1:58,776,845...58,784,048
G
JUNB
JunB proto-oncogene, AP-1 transcription factor subunit
decreases expression
EXP
obeticholic acid results in decreased expression of JUNB mRNA
CTD
PMID:27939613
NCBI chr19:12,791,486...12,793,315
Ensembl chr19:12,791,486...12,793,315
G
JUND
JunD proto-oncogene, AP-1 transcription factor subunit
multiple interactions
ISO
NR0B2 protein affects the reaction [obeticholic acid inhibits the reaction [JUND protein binds to TIMP1 promoter]]
CTD
PMID:15860571
NCBI chr19:18,279,694...18,281,622
Ensembl chr19:18,279,694...18,281,622
G
KRT16P2
keratin 16 pseudogene 2
decreases expression
EXP
obeticholic acid results in decreased expression of KRT16P2 mRNA
CTD
PMID:27939613
NCBI chr17:16,830,483...16,832,833
Ensembl chr17:16,829,999...16,832,753
G
KRT16P3
keratin 16 pseudogene 3
decreases expression
EXP
obeticholic acid results in decreased expression of KRT16P3 mRNA
CTD
PMID:27939613
NCBI chr17:20,501,513...20,504,498
Ensembl chr17:20,501,513...20,512,357 Ensembl chr17:20,501,513...20,512,357
G
KRT18
keratin 18
multiple interactions
ISO
[Dietary Fats co-treated with obeticholic acid] results in decreased expression of KRT18 mRNA
CTD
PMID:35267068
NCBI chr12:52,948,855...52,952,906
Ensembl chr12:52,948,871...52,952,906
G
LBR
lamin B receptor
decreases expression
EXP
obeticholic acid results in decreased expression of LBR mRNA
CTD
PMID:27939613
NCBI chr 1:225,401,502...225,428,821
Ensembl chr 1:225,401,502...225,428,925
G
LCAT
lecithin-cholesterol acyltransferase
decreases expression
EXP
obeticholic acid results in decreased expression of LCAT mRNA
CTD
PMID:27939613
NCBI chr16:67,939,750...67,944,120
Ensembl chr16:67,939,750...67,944,131
G
LDLR
low density lipoprotein receptor
decreases expression
EXP
obeticholic acid results in decreased expression of LDLR mRNA
CTD
PMID:27939613
NCBI chr19:11,089,463...11,133,820
Ensembl chr19:11,089,418...11,133,820
G
LENG8
leukocyte receptor cluster member 8
increases expression
EXP
obeticholic acid results in increased expression of LENG8 mRNA
CTD
PMID:27939613
NCBI chr19:54,449,199...54,462,016
Ensembl chr19:54,449,190...54,462,016
G
LGI4
leucine rich repeat LGI family member 4
increases expression
EXP
obeticholic acid results in increased expression of LGI4 mRNA
CTD
PMID:27939613
NCBI chr19:35,124,513...35,135,059
Ensembl chr19:35,124,513...35,142,451
G
LIME1
Lck interacting transmembrane adaptor 1
decreases expression
EXP
obeticholic acid results in decreased expression of LIME1 mRNA
CTD
PMID:27939613
NCBI chr20:63,735,701...63,739,103
Ensembl chr20:63,736,283...63,739,103
G
LINC00870
long intergenic non-protein coding RNA 870
increases expression
EXP
obeticholic acid results in increased expression of LINC00870 mRNA
CTD
PMID:27939613
NCBI chr 3:72,151,257...72,174,339
Ensembl chr 3:72,151,236...72,207,776
G
LIPC
lipase C, hepatic type
decreases expression
EXP
obeticholic acid results in decreased expression of LIPC mRNA
CTD
PMID:27939613
NCBI chr15:58,431,991...58,569,844
Ensembl chr15:58,410,569...58,569,844
G
LPA
lipoprotein(a)
decreases expression
EXP
obeticholic acid results in decreased expression of LPA mRNA
CTD
PMID:27939613
NCBI chr 6:160,531,482...160,664,275
Ensembl chr 6:160,531,482...160,664,275
G
LPIN1
lipin 1
decreases expression
EXP
obeticholic acid results in decreased expression of LPIN1 mRNA
CTD
PMID:27939613
NCBI chr 2:11,677,544...11,827,409
Ensembl chr 2:11,677,595...11,827,409
G
LPIN2
lipin 2
decreases expression
EXP
obeticholic acid results in decreased expression of LPIN2 mRNA
CTD
PMID:27939613
NCBI chr18:2,916,994...3,013,144
Ensembl chr18:2,885,296...3,013,144
G
LSS
lanosterol synthase
decreases expression
EXP
obeticholic acid results in decreased expression of LSS mRNA
CTD
PMID:27939613
NCBI chr21:46,188,446...46,228,774
Ensembl chr21:46,188,141...46,228,824
G
MAF
MAF bZIP transcription factor
increases expression
EXP
obeticholic acid results in increased expression of MAF mRNA
CTD
PMID:27939613
NCBI chr16:79,202,622...79,600,737
Ensembl chr16:79,585,843...79,600,737
G
MAFF
MAF bZIP transcription factor F
increases expression
EXP
obeticholic acid results in increased expression of MAFF mRNA
CTD
PMID:27939613
NCBI chr22:38,201,994...38,216,511
Ensembl chr22:38,200,767...38,216,507
G
MAP1LC3B
microtubule associated protein 1 light chain 3 beta
multiple interactions
ISO
obeticholic acid inhibits the reaction [Dietary Fats results in decreased expression of MAP1LC3B protein]
CTD
PMID:26655953
NCBI chr16:87,392,336...87,404,774
Ensembl chr16:87,383,953...87,404,779
G
MAP2K3
mitogen-activated protein kinase kinase 3
decreases expression
EXP
obeticholic acid results in decreased expression of MAP2K3 mRNA
CTD
PMID:27939613
NCBI chr17:21,284,711...21,315,240
Ensembl chr17:21,284,672...21,315,232
G
MAP2K6
mitogen-activated protein kinase kinase 6
decreases expression
EXP
obeticholic acid results in decreased expression of MAP2K6 mRNA
CTD
PMID:27939613
NCBI chr17:69,414,697...69,553,865
Ensembl chr17:69,414,697...69,553,865
G
MAP2K7
mitogen-activated protein kinase kinase 7
decreases expression
EXP
obeticholic acid results in decreased expression of MAP2K7 mRNA
CTD
PMID:27939613
NCBI chr19:7,903,877...7,914,478
Ensembl chr19:7,903,843...7,914,478
G
MAP3K14
mitogen-activated protein kinase kinase kinase 14
decreases expression
EXP
obeticholic acid results in decreased expression of MAP3K14 mRNA
CTD
PMID:27939613
NCBI chr17:45,263,119...45,317,020
Ensembl chr17:45,263,119...45,317,029
G
MAP3K5
mitogen-activated protein kinase kinase kinase 5
decreases expression
EXP
obeticholic acid results in decreased expression of MAP3K5 mRNA
CTD
PMID:27939613
NCBI chr 6:136,557,046...136,793,091
Ensembl chr 6:136,557,046...136,793,097
G
MAP3K8
mitogen-activated protein kinase kinase kinase 8
increases expression
EXP
obeticholic acid results in increased expression of MAP3K8 mRNA
CTD
PMID:27939613
NCBI chr10:30,434,021...30,461,833
Ensembl chr10:30,434,021...30,461,833
G
MAPK1
mitogen-activated protein kinase 1
multiple interactions
ISO
obeticholic acid inhibits the reaction [Carbon Tetrachloride results in increased phosphorylation of MAPK1 protein]
CTD
PMID:27865854
NCBI chr22:21,759,657...21,867,680
Ensembl chr22:21,759,657...21,867,680
G
MAPK11
mitogen-activated protein kinase 11
decreases expression
EXP
obeticholic acid results in decreased expression of MAPK11 mRNA
CTD
PMID:27939613
NCBI chr22:50,263,713...50,270,380
Ensembl chr22:50,263,713...50,270,767
G
MAPK12
mitogen-activated protein kinase 12
decreases expression
EXP
obeticholic acid results in decreased expression of MAPK12 mRNA
CTD
PMID:27939613
NCBI chr22:50,252,901...50,261,683
Ensembl chr22:50,245,450...50,261,716
G
MAPK3
mitogen-activated protein kinase 3
multiple interactions
ISO
obeticholic acid inhibits the reaction [Carbon Tetrachloride results in increased phosphorylation of MAPK3 protein]
CTD
PMID:27865854
NCBI chr16:30,114,105...30,123,220
Ensembl chr16:30,114,105...30,123,506
G
MDH1
malate dehydrogenase 1
increases expression
EXP
obeticholic acid results in increased expression of MDH1 mRNA
CTD
PMID:27939613
NCBI chr 2:63,588,963...63,607,197
Ensembl chr 2:63,588,609...63,607,197
G
METRNL
meteorin like, glial cell differentiation regulator
decreases expression
EXP
obeticholic acid results in decreased expression of METRNL mRNA
CTD
PMID:27939613
NCBI chr17:83,079,609...83,095,122
Ensembl chr17:83,079,609...83,095,122
G
MFSD2A
MFSD2 lysolipid transporter A, lysophospholipid
increases expression
EXP
obeticholic acid results in increased expression of MFSD2A mRNA
CTD
PMID:27939613
NCBI chr 1:39,955,145...39,969,956
Ensembl chr 1:39,955,112...39,969,968
G
MLKL
mixed lineage kinase domain like pseudokinase
decreases expression
EXP
obeticholic acid results in decreased expression of MLKL mRNA
CTD
PMID:27939613
NCBI chr16:74,671,855...74,700,862
Ensembl chr16:74,671,855...74,700,960
G
MLLT11
MLLT11 transcription factor 7 cofactor
increases expression
EXP
obeticholic acid results in increased expression of MLLT11 mRNA
CTD
PMID:27939613
NCBI chr 1:151,060,397...151,069,544
Ensembl chr 1:151,060,397...151,069,544
G
MMP2
matrix metallopeptidase 2
increases activity
ISO
obeticholic acid results in increased activity of MMP2 protein
CTD
PMID:15860571
NCBI chr16:55,478,830...55,506,691
Ensembl chr16:55,389,700...55,506,691
G
MPO
myeloperoxidase
multiple interactions
ISO
obeticholic acid inhibits the reaction [[triptolide co-treated with Lipopolysaccharides] results in increased expression of MPO protein]
CTD
PMID:36328986
NCBI chr17:58,269,855...58,280,935
Ensembl chr17:58,269,855...58,280,935
G
MRTFB
myocardin related transcription factor B
decreases expression
EXP
obeticholic acid results in decreased expression of MRTFB mRNA
CTD
PMID:27939613
NCBI chr16:13,994,774...14,266,779
Ensembl chr16:14,071,319...14,266,773
G
MSMO1
methylsterol monooxygenase 1
decreases expression
EXP
obeticholic acid results in decreased expression of MSMO1 mRNA
CTD
PMID:27939613
NCBI chr 4:165,327,669...165,343,164
Ensembl chr 4:165,327,667...165,343,164
G
MT1H
metallothionein 1H
decreases expression
EXP
obeticholic acid results in decreased expression of MT1H mRNA
CTD
PMID:27939613
NCBI chr16:56,669,814...56,671,129
Ensembl chr16:56,669,814...56,671,129
G
MVD
mevalonate diphosphate decarboxylase
decreases expression
EXP
obeticholic acid results in decreased expression of MVD mRNA
CTD
PMID:27939613
NCBI chr16:88,651,940...88,663,091
Ensembl chr16:88,651,935...88,663,161
G
MVK
mevalonate kinase
decreases expression
EXP
obeticholic acid results in decreased expression of MVK mRNA
CTD
PMID:27939613
NCBI chr12:109,573,272...109,598,125
Ensembl chr12:109,573,255...109,598,125
G
MYC
MYC proto-oncogene, bHLH transcription factor
decreases expression
EXP
obeticholic acid results in decreased expression of MYC mRNA
CTD
PMID:27939613
NCBI chr 8:127,735,434...127,742,951
Ensembl chr 8:127,735,434...127,742,951
G
MYD88
MYD88 innate immune signal transduction adaptor
multiple interactions
ISO
obeticholic acid inhibits the reaction [Methamphetamine results in increased expression of MYD88 protein]
CTD
PMID:35688268 PMID:36720452
NCBI chr 3:38,138,661...38,143,022
Ensembl chr 3:38,138,552...38,143,024
G
NFE2L2
NFE2 like bZIP transcription factor 2
increases expression multiple interactions
EXP ISO
obeticholic acid results in increased expression of NFE2L2 mRNA [Dietary Fats co-treated with obeticholic acid] results in decreased expression of NFE2L2 protein
CTD
PMID:27939613 PMID:35267068
NCBI chr 2:177,230,303...177,264,727
Ensembl chr 2:177,218,667...177,392,756
G
NFKB1
nuclear factor kappa B subunit 1
increases expression multiple interactions
EXP ISO
obeticholic acid results in increased expression of NFKB1 mRNA Obeticholic acid inhibits the reaction [ethanol increases expression of NF-kB protein in liver]
CTD RGD
PMID:27939613 PMID:27939985
RGD:15036816
NCBI chr 4:102,501,359...102,617,302
Ensembl chr 4:102,501,330...102,617,302
G
NFKB2
nuclear factor kappa B subunit 2
decreases expression
EXP
obeticholic acid results in decreased expression of NFKB2 mRNA
CTD
PMID:27939613
NCBI chr10:102,394,110...102,402,529
Ensembl chr10:102,394,110...102,402,524
G
NFKBIA
NFKB inhibitor alpha
multiple interactions
ISO
Obeticholic acid inhibits the reaction [ethanol decreases expression of Nfkbia protein in liver]
RGD
PMID:27939985
RGD:15036816
NCBI chr14:35,401,513...35,404,749
Ensembl chr14:35,401,079...35,404,749
G
NLRP3
NLR family pyrin domain containing 3
multiple interactions
ISO
Obeticholic acid inhibits the reaction [ethanol increases expression of Nrlp3 protein in liver]
RGD
PMID:27939985
RGD:15036816
NCBI chr 1:247,416,077...247,448,817
Ensembl chr 1:247,332,331...247,449,108
G
NPW
neuropeptide W
decreases expression
EXP
obeticholic acid results in decreased expression of NPW mRNA
CTD
PMID:27939613
NCBI chr16:2,019,785...2,020,755
Ensembl chr16:2,009,926...2,020,755
G
NR0B2
nuclear receptor subfamily 0 group B member 2
multiple interactions increases expression
EXP ISO
obeticholic acid promotes the reaction [PRMT2 protein binds to NR0B2 promoter] obeticholic acid inhibits the reaction [1-Naphthylisothiocyanate results in decreased expression of NR0B2 protein]; obeticholic acid inhibits the reaction [[triptolide co-treated with Lipopolysaccharides] results in decreased expression of NR0B2 protein]; obeticholic acid inhibits the reaction [Dietary Fats results in decreased expression of NR0B2 mRNA] Obeticholic acid inhibits the reaction [ethanol decreases expression of Nr0b2 protein in liver and intestine] NR0B2 protein affects the reaction [obeticholic acid inhibits the reaction [JUND protein binds to TIMP1 promoter]]; NR0B2 protein affects the reaction [obeticholic acid results in decreased expression of and results in decreased secretion of TIMP1 protein]; obeticholic acid inhibits the reaction [Isoniazid results in decreased expression of NR0B2 mRNA]; obeticholic acid inhibits the reaction [Pyrazinamide results in decreased expression of NR0B2 mRNA] obeticholic acid results in increased expression of NR0B2 mRNA; obeticholic acid results in increased expression of NR0B2 protein
CTD RGD
PMID:15644430 PMID:15860571 PMID:15911693 PMID:15980055 PMID:26655953 PMID:27255380 PMID:27939613 PMID:32673658 PMID:35267068 PMID:36328986 PMID:36787806 PMID:27939985 More...
RGD:15036816
NCBI chr 1:26,911,489...26,913,975
Ensembl chr 1:26,911,489...26,913,975
G
NR1H4
nuclear receptor subfamily 1 group H member 4
increases activity multiple interactions increases expression increases response to substance
EXP ISO
obeticholic acid results in increased activity of NR1H4 protein Obeticholic acid inhibits the reaction [ethanol decreases expression of Nr1h4 mRNA and protein in liver and liver cell nuclei and intestine] obeticholic acid increases expression of Nr1H4 mRNA in rat hepatic stellate cells; obeticholic acid increases expression of Nr1h4 mRNA in bile duct ligation and porcine serum induced models of cirrhosis in rat obeticholic acid results in increased expression of NR1H4 protein obeticholic acid results in increased expression of NR1H4 mRNA obeticholic acid binds to and results in increased activity of NR1H4 protein; obeticholic acid inhibits the reaction [Isoniazid results in decreased expression of NR1H4 mRNA]; obeticholic acid inhibits the reaction [Pyrazinamide results in decreased expression of NR1H4 mRNA] NR1H4 protein results in increased susceptibility to obeticholic acid [obeticholic acid co-treated with 1-Naphthylisothiocyanate] results in increased expression of NR1H4 protein; NR1H4 affects the reaction [obeticholic acid results in increased expression of FOXM1 mRNA]; NR1H4 gene mutant form inhibits the reaction [obeticholic acid inhibits the reaction [TNF results in increased expression of SELP mRNA]]; NR1H4 gene mutant form inhibits the reaction [obeticholic acid results in increased expression of FABP6 mRNA]; NR1H4 gene mutant form inhibits the reaction [obeticholic acid results in increased expression of FGF15 mRNA]; NR1H4 promotes the reaction [obeticholic acid promotes the reaction [1-Naphthylisothiocyanate results in increased expression of ABCC2 mRNA]]; obeticholic acid binds to and results in increased activity of NR1H4 protein; obeticholic acid inhibits the reaction [1-Naphthylisothiocyanate results in decreased expression of NR1H4 mRNA]; obeticholic acid inhibits the reaction [[triptolide co-treated with Lipopolysaccharides] results in decreased expression of NR1H4 protein]; obeticholic acid inhibits the reaction [Methamphetamine results in increased expression of NR1H4 mRNA]; obeticholic acid inhibits the reaction [Methamphetamine results in increased expression of NR1H4 protein] obeticholic acid binds to and results in increased activity of NR1H4 protein; obeticholic acid promotes the reaction [NR1H4 protein binds to PRMT1 protein]
CTD RGD
PMID:15860571 PMID:15911693 PMID:15980055 PMID:17567710 PMID:21242261 PMID:22135065 PMID:22918042 PMID:27255380 PMID:27865854 PMID:27871908 PMID:28887089 PMID:29660435 PMID:32673658 PMID:35688268 PMID:36328986 PMID:36787806 PMID:27939985 PMID:15980055 More...
RGD:15036816 , RGD:1625201
NCBI chr12:100,473,866...100,564,414
Ensembl chr12:100,473,708...100,564,414
G
NR5A2
nuclear receptor subfamily 5 group A member 2
decreases expression
EXP
obeticholic acid results in decreased expression of NR5A2 mRNA
CTD
PMID:27939613
NCBI chr 1:200,027,710...200,177,415
Ensembl chr 1:200,027,614...200,177,420
G
OCLN
occludin
multiple interactions
ISO
obeticholic acid inhibits the reaction [Methamphetamine results in decreased expression of OCLN protein]; obeticholic acid promotes the reaction [[Dietary Fats co-treated with Dextran Sulfate] results in increased expression of OCLN protein]
CTD
PMID:35439472 PMID:36720452
NCBI chr 5:69,492,547...69,558,104
Ensembl chr 5:69,492,292...69,558,104
G
P4HB
prolyl 4-hydroxylase subunit beta
increases expression
EXP
obeticholic acid results in increased expression of P4HB mRNA
CTD
PMID:27939613
NCBI chr17:81,843,166...81,860,535
Ensembl chr17:81,843,159...81,860,856
G
PC
pyruvate carboxylase
decreases expression
EXP
obeticholic acid results in decreased expression of PC mRNA
CTD
PMID:27939613
NCBI chr11:66,848,420...66,958,383
Ensembl chr11:66,848,417...66,958,386
G
PCK1
phosphoenolpyruvate carboxykinase 1
decreases expression
EXP
obeticholic acid results in decreased expression of PCK1 mRNA
CTD
PMID:27939613
NCBI chr20:57,561,110...57,568,121
Ensembl chr20:57,561,080...57,568,121
G
PFKFB1
6-phosphofructo-2-kinase/fructose-2,6-biphosphatase 1
increases expression
EXP
obeticholic acid results in increased expression of PFKFB1 mRNA
CTD
PMID:27939613
NCBI chr X:54,932,961...54,998,789
Ensembl chr X:54,932,961...54,998,534
G
PGM1
phosphoglucomutase 1
decreases expression
EXP
obeticholic acid results in decreased expression of PGM1 mRNA
CTD
PMID:27939613
NCBI chr 1:63,593,411...63,660,245
Ensembl chr 1:63,593,411...63,660,245
G
PIK3CD
phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit delta
decreases expression
EXP
obeticholic acid results in decreased expression of PIK3CD mRNA
CTD
PMID:27939613
NCBI chr 1:9,627,258...9,729,114
Ensembl chr 1:9,629,889...9,729,114
G
PIK3R1
phosphoinositide-3-kinase regulatory subunit 1
decreases expression
EXP
obeticholic acid results in decreased expression of PIK3R1 mRNA
CTD
PMID:27939613
NCBI chr 5:68,215,756...68,301,821
Ensembl chr 5:68,215,740...68,301,821
G
PKD1P1
polycystin 1, transient receptor potential channel interacting pseudogene 1
decreases expression
EXP
obeticholic acid results in decreased expression of PKD1P1 mRNA
CTD
PMID:27939613
NCBI chr16:16,310,134...16,332,477
Ensembl chr16:16,310,341...16,334,190
G
PLTP
phospholipid transfer protein
decreases expression
EXP
obeticholic acid results in decreased expression of PLTP mRNA
CTD
PMID:27939613
NCBI chr20:45,898,620...45,912,155
Ensembl chr20:45,898,621...45,912,155
G
PPARA
peroxisome proliferator activated receptor alpha
multiple interactions increases expression
ISO EXP
Palmitic Acid inhibits the reaction [obeticholic acid results in increased expression of PPARA mRNA] Obeticholic acid inhibits the reaction [ethanol decreases expression of Ppara mRNA and protein in liver] obeticholic acid inhibits the reaction [Ethanol results in decreased expression of PPARA protein] obeticholic acid results in increased expression of PPARA mRNA; obeticholic acid results in increased expression of PPARA protein
CTD RGD
PMID:15980055 PMID:26655953 PMID:27939985 PMID:27939985
RGD:15036816
NCBI chr22:46,150,526...46,243,756
Ensembl chr22:46,150,521...46,243,755
G
PPARG
peroxisome proliferator activated receptor gamma
increases expression
ISO
obeticholic acid results in increased expression of PPARG mRNA; obeticholic acid results in increased expression of PPARG protein
CTD
PMID:15980055
NCBI chr 3:12,287,368...12,434,344
Ensembl chr 3:12,287,368...12,434,356
G
PPP1R3C
protein phosphatase 1 regulatory subunit 3C
decreases expression
EXP
obeticholic acid results in decreased expression of PPP1R3C mRNA
CTD
PMID:27939613
NCBI chr10:91,628,442...91,633,071
Ensembl chr10:91,628,442...91,633,071
G
PPP2CB
protein phosphatase 2 catalytic subunit beta
increases expression
EXP
obeticholic acid results in increased expression of PPP2CB mRNA
CTD
PMID:27939613
NCBI chr 8:30,785,616...30,812,818
Ensembl chr 8:30,774,457...30,814,314
G
PPP2R1B
protein phosphatase 2 scaffold subunit Abeta
increases expression
EXP
obeticholic acid results in increased expression of PPP2R1B mRNA
CTD
PMID:27939613
NCBI chr11:111,688,000...111,766,389
Ensembl chr11:111,726,908...111,766,389
G
PRDX1
peroxiredoxin 1
decreases expression
EXP
obeticholic acid results in decreased expression of PRDX1 mRNA
CTD
PMID:27939613
NCBI chr 1:45,511,051...45,522,890
Ensembl chr 1:45,510,914...45,542,732
G
PRDX6
peroxiredoxin 6
decreases expression
EXP
obeticholic acid results in decreased expression of PRDX6 mRNA
CTD
PMID:27939613
NCBI chr 1:173,477,335...173,488,815
Ensembl chr 1:173,477,330...173,488,815
G
PRKCA
protein kinase C alpha
increases expression
EXP
obeticholic acid results in increased expression of PRKCA mRNA
CTD
PMID:27939613
NCBI chr17:66,302,613...66,810,743
Ensembl chr17:66,302,613...66,810,743
G
PRKCE
protein kinase C epsilon
increases expression
EXP
obeticholic acid results in increased expression of PRKCE mRNA
CTD
PMID:27939613
NCBI chr 2:45,651,279...46,187,990
Ensembl chr 2:45,651,345...46,187,990
G
PRMT1
protein arginine methyltransferase 1
multiple interactions increases activity
EXP
obeticholic acid promotes the reaction [NR1H4 protein binds to PRMT1 protein]; obeticholic acid promotes the reaction [PRMT1 protein binds to ABCB11 promoter] obeticholic acid results in increased activity of PRMT1 protein
CTD
PMID:15911693
NCBI chr19:49,676,153...49,688,447
Ensembl chr19:49,675,786...49,689,029
G
PRMT2
protein arginine methyltransferase 2
multiple interactions
EXP
obeticholic acid promotes the reaction [PRMT2 protein binds to NR0B2 promoter]
CTD
PMID:15911693
NCBI chr21:46,635,674...46,665,124
Ensembl chr21:46,635,595...46,665,124
G
PTBP2
polypyrimidine tract binding protein 2
decreases expression
EXP
obeticholic acid results in decreased expression of PTBP2 mRNA
CTD
PMID:27939613
NCBI chr 1:96,721,784...96,823,739
Ensembl chr 1:96,721,665...96,823,738
G
RELA
RELA proto-oncogene, NF-kB subunit
multiple interactions
ISO
obeticholic acid inhibits the reaction [1-Naphthylisothiocyanate results in increased expression of RELA protein]; obeticholic acid inhibits the reaction [Methamphetamine results in increased expression of and results in increased phosphorylation of RELA protein]; obeticholic acid inhibits the reaction [Methamphetamine results in increased expression of RELA protein]
CTD
PMID:29660435 PMID:35688268 PMID:36720452
NCBI chr11:65,653,601...65,663,857
Ensembl chr11:65,653,599...65,663,090
G
ROS1
ROS proto-oncogene 1, receptor tyrosine kinase
increases expression
EXP
obeticholic acid results in increased expression of ROS1 mRNA
CTD
PMID:27939613
NCBI chr 6:117,287,353...117,425,942
Ensembl chr 6:117,287,353...117,425,942
G
RPS6KA2
ribosomal protein S6 kinase A2
increases expression
EXP
obeticholic acid results in increased expression of RPS6KA2 mRNA
CTD
PMID:27939613
NCBI chr 6:166,409,364...166,862,773
Ensembl chr 6:166,409,364...166,906,451
G
RPS6KA4
ribosomal protein S6 kinase A4
decreases expression
EXP
obeticholic acid results in decreased expression of RPS6KA4 mRNA
CTD
PMID:27939613
NCBI chr11:64,359,162...64,372,215
Ensembl chr11:64,359,148...64,372,215
G
RPS6KA5
ribosomal protein S6 kinase A5
decreases expression
EXP
obeticholic acid results in decreased expression of RPS6KA5 mRNA
CTD
PMID:27939613
NCBI chr14:90,847,861...91,060,641
Ensembl chr14:90,847,861...91,060,641
G
RRAS2
RAS related 2
increases expression
EXP
obeticholic acid results in increased expression of RRAS2 mRNA
CTD
PMID:27939613
NCBI chr11:14,277,920...14,364,506
Ensembl chr11:14,277,922...14,364,506
G
RTP3
receptor transporter protein 3
increases expression
EXP
obeticholic acid results in increased expression of RTP3 mRNA
CTD
PMID:27939613
NCBI chr 3:46,497,976...46,500,950
Ensembl chr 3:46,494,611...46,500,950
G
RXRA
retinoid X receptor alpha
decreases expression
EXP
obeticholic acid results in decreased expression of RXRA mRNA
CTD
PMID:27939613
NCBI chr 9:134,326,455...134,440,585
Ensembl chr 9:134,317,098...134,440,585
G
S100A3
S100 calcium binding protein A3
decreases expression
EXP
obeticholic acid results in decreased expression of S100A3 mRNA
CTD
PMID:27939613
NCBI chr 1:153,547,329...153,549,258
Ensembl chr 1:153,547,329...153,549,258
G
SAA1
serum amyloid A1
increases expression
EXP
obeticholic acid results in increased expression of SAA1 mRNA
CTD
PMID:27939613
NCBI chr11:18,266,264...18,269,967
Ensembl chr11:18,266,260...18,269,977
G
SC5D
sterol-C5-desaturase
decreases expression
EXP
obeticholic acid results in decreased expression of SC5D mRNA
CTD
PMID:27939613
NCBI chr11:121,292,771...121,313,410
Ensembl chr11:121,292,681...121,313,410
G
SCARB1
scavenger receptor class B member 1
increases expression
EXP
obeticholic acid results in increased expression of SCARB1 mRNA
CTD
PMID:27939613
NCBI chr12:124,776,856...124,863,864
Ensembl chr12:124,776,856...124,882,668
G
SDC1
syndecan 1
increases expression
EXP
obeticholic acid results in increased expression of SDC1 mRNA
CTD
PMID:27939613
NCBI chr 2:20,200,797...20,225,475
Ensembl chr 2:20,200,797...20,225,433
G
SDHA
succinate dehydrogenase complex flavoprotein subunit A
multiple interactions
ISO
obeticholic acid inhibits the reaction [Dietary Fats results in decreased expression of SDHA protein]
CTD
PMID:26655953
NCBI chr 5:218,320...268,746
Ensembl chr 5:218,303...257,082
G
SELP
selectin P
multiple interactions
ISO
NR1H4 gene mutant form inhibits the reaction [obeticholic acid inhibits the reaction [TNF results in increased expression of SELP mRNA]]; obeticholic acid inhibits the reaction [TNF results in increased expression of SELP mRNA]
CTD
PMID:22135065
NCBI chr 1:169,588,849...169,630,124
Ensembl chr 1:169,588,849...169,630,193
G
SERPINA1
serpin family A member 1
decreases expression
EXP
obeticholic acid results in decreased expression of SERPINA1 mRNA
CTD
PMID:27939613
NCBI chr14:94,376,747...94,390,635
Ensembl chr14:94,376,747...94,390,693
G
SERPINE1
serpin family E member 1
decreases expression
EXP
obeticholic acid results in decreased expression of SERPINE1 mRNA
CTD
PMID:27939613
NCBI chr 7:101,127,104...101,139,247
Ensembl chr 7:101,127,104...101,139,247
G
SFN
stratifin
decreases expression
EXP
obeticholic acid results in decreased expression of SFN mRNA
CTD
PMID:27939613
NCBI chr 1:26,863,149...26,864,456
Ensembl chr 1:26,863,149...26,864,456
G
SIGIRR
single Ig and TIR domain containing
decreases expression
EXP
obeticholic acid results in decreased expression of SIGIRR mRNA
CTD
PMID:27939613
NCBI chr11:405,716...417,397
Ensembl chr11:405,715...417,455
G
SLC10A1
solute carrier family 10 member 1
decreases expression multiple interactions
EXP ISO
obeticholic acid results in decreased expression of SLC10A1 mRNA obeticholic acid promotes the reaction [Isoniazid results in decreased expression of SLC10A1 mRNA] Obeticholic acid inhibits the reaction [ethanol decreases expression of Slc10a1 protein in liver] [1-Naphthylisothiocyanate co-treated with obeticholic acid] results in decreased expression of SLC10A1 protein; obeticholic acid inhibits the reaction [[triptolide co-treated with Lipopolysaccharides] results in decreased expression of SLC10A1 mRNA]; obeticholic acid promotes the reaction [1-Naphthylisothiocyanate results in decreased expression of SLC10A1 mRNA]; obeticholic acid promotes the reaction [1-Naphthylisothiocyanate results in decreased expression of SLC10A1 protein]
CTD RGD
PMID:15644430 PMID:15911693 PMID:29660435 PMID:32673658 PMID:36328986 PMID:36787806 PMID:27939985 More...
RGD:15036816
NCBI chr14:69,775,416...69,797,241
Ensembl chr14:69,775,416...69,797,241
G
SLC13A5
solute carrier family 13 member 5
decreases expression
EXP
obeticholic acid results in decreased expression of SLC13A5 mRNA
CTD
PMID:27939613
NCBI chr17:6,684,719...6,713,369
Ensembl chr17:6,684,719...6,713,377
G
SLC25A1
solute carrier family 25 member 1
decreases expression
EXP
obeticholic acid results in decreased expression of SLC25A1 mRNA
CTD
PMID:27939613
NCBI chr22:19,175,581...19,178,736
Ensembl chr22:19,175,581...19,178,739
G
SLC25A10
solute carrier family 25 member 10
decreases expression
EXP
obeticholic acid results in decreased expression of SLC25A10 mRNA
CTD
PMID:27939613
NCBI chr17:81,712,284...81,721,012
Ensembl chr17:81,712,236...81,721,016
G
SLC25A12
solute carrier family 25 member 12
decreases expression
EXP
obeticholic acid results in decreased expression of SLC25A12 mRNA
CTD
PMID:27939613
NCBI chr 2:171,783,405...171,894,244
Ensembl chr 2:171,783,405...171,999,859
G
SLC27A5
solute carrier family 27 member 5
decreases expression
EXP
obeticholic acid results in decreased expression of SLC27A5 mRNA
CTD
PMID:27939613
NCBI chr19:58,498,333...58,511,992
Ensembl chr19:58,479,512...58,512,413
G
SLC51A
solute carrier family 51 member A
increases expression
ISO EXP
obeticholic acid results in increased expression of SLC51A mRNA; obeticholic acid results in increased expression of SLC51A protein
CTD
PMID:26655953 PMID:27939613
NCBI chr 3:196,216,534...196,233,427
Ensembl chr 3:196,211,487...196,243,178
G
SLC51B
SLC51 subunit beta
increases expression multiple interactions
ISO EXP
obeticholic acid results in increased expression of SLC51B mRNA obeticholic acid inhibits the reaction [Pyrazinamide results in decreased expression of SLC51B mRNA]
CTD
PMID:26655953 PMID:27255380 PMID:27939613
NCBI chr15:65,045,387...65,053,397
Ensembl chr15:65,045,387...65,053,397
G
SLCO1B1
solute carrier organic anion transporter family member 1B1
decreases expression
EXP
obeticholic acid results in decreased expression of SLCO1B1 mRNA
CTD
PMID:27939613
NCBI chr12:21,131,194...21,239,796
Ensembl chr12:21,131,194...21,239,796
G
SLCO1B3
solute carrier organic anion transporter family member 1B3
increases expression multiple interactions
EXP ISO
obeticholic acid results in increased expression of SLCO1B3 mRNA obeticholic acid inhibits the reaction [Pyrazinamide results in decreased expression of SLCO1B2 mRNA] obeticholic acid results in increased expression of SLCO1B2 mRNA
CTD
PMID:27255380 PMID:27939613
NCBI chr12:20,810,705...20,916,911
Ensembl chr12:20,810,702...20,916,911
G
SOCS2
suppressor of cytokine signaling 2
decreases expression
EXP
obeticholic acid results in decreased expression of SOCS2 mRNA
CTD
PMID:27939613
NCBI chr12:93,569,969...93,626,236
Ensembl chr12:93,569,814...93,583,487
G
SOD2
superoxide dismutase 2
decreases expression
EXP
obeticholic acid results in decreased expression of SOD2 mRNA
CTD
PMID:27939613
NCBI chr 6:159,669,069...159,762,281
Ensembl chr 6:159,669,069...159,762,529
G
SQSTM1
sequestosome 1
multiple interactions
ISO
obeticholic acid inhibits the reaction [Dietary Fats results in decreased expression of SQSTM1 protein]
CTD
PMID:26655953
NCBI chr 5:179,806,393...179,838,078
Ensembl chr 5:179,806,398...179,838,078
G
SREBF1
sterol regulatory element binding transcription factor 1
multiple interactions decreases expression
EXP ISO
obeticholic acid inhibits the reaction [Ethanol results in increased expression of SREBF1 protein] Obeticholic acid inhibits the reaction [ethanol increases expression of Srebf1 mRNA and protein in liver] obeticholic acid results in decreased expression of SREBF1 mRNA
CTD RGD
PMID:27939613 PMID:27939985 PMID:27939985
RGD:15036816
NCBI chr17:17,811,334...17,836,986
Ensembl chr17:17,810,399...17,837,002
G
SREBF2
sterol regulatory element binding transcription factor 2
multiple interactions decreases expression
ISO EXP
obeticholic acid inhibits the reaction [Dietary Fats results in increased expression of SREBF2 mRNA] obeticholic acid results in decreased expression of SREBF2 mRNA
CTD
PMID:26655953 PMID:27939613
NCBI chr22:41,833,105...41,907,305
Ensembl chr22:41,833,105...41,907,306
G
SULT2A1
sulfotransferase family 2A member 1
multiple interactions
ISO
obeticholic acid promotes the reaction [1-Naphthylisothiocyanate results in increased expression of SULT2A1 mRNA]
CTD
PMID:29660435
NCBI chr19:47,870,467...47,886,315
Ensembl chr19:47,870,467...47,886,315
G
SZRD1
SUZ RNA binding domain containing 1
increases expression
EXP
obeticholic acid results in increased expression of SZRD1 mRNA
CTD
PMID:27939613
NCBI chr 1:16,367,242...16,398,145
Ensembl chr 1:16,352,575...16,398,145
G
TAB1
TGF-beta activated kinase 1 (MAP3K7) binding protein 1
decreases expression
EXP
obeticholic acid results in decreased expression of TAB1 mRNA
CTD
PMID:27939613
NCBI chr22:39,399,780...39,437,132
Ensembl chr22:39,399,778...39,437,060
G
TAPBP
TAP binding protein
decreases expression
EXP
obeticholic acid results in decreased expression of TAPBP mRNA
CTD
PMID:27939613
NCBI chr 6:33,299,694...33,314,078
Ensembl chr 6:33,299,694...33,314,284
G
TCEA2
transcription elongation factor A2
increases expression
EXP
obeticholic acid results in increased expression of TCEA2 mRNA
CTD
PMID:27939613
NCBI chr20:64,055,596...64,072,347
Ensembl chr20:64,049,836...64,072,347
G
TECR
trans-2,3-enoyl-CoA reductase
decreases expression
EXP
obeticholic acid results in decreased expression of TECR mRNA
CTD
PMID:27939613
NCBI chr19:14,527,726...14,565,980
Ensembl chr19:14,517,085...14,565,980
G
TEDC1
tubulin epsilon and delta complex 1
decreases expression
EXP
obeticholic acid results in decreased expression of TEDC1 mRNA
CTD
PMID:27939613
NCBI chr14:105,489,855...105,499,248
Ensembl chr14:105,489,855...105,499,575
G
TGFB1
transforming growth factor beta 1
multiple interactions decreases expression
ISO EXP
obeticholic acid inhibits the reaction [TGFB1 protein results in increased expression of COL1A1 mRNA] obeticholic acid inhibits the reaction [[Dietary Fats co-treated with Dextran Sulfate] results in increased expression of TGFB1 protein] obeticholic acid results in decreased expression of TGFB1 mRNA
CTD
PMID:15980055 PMID:27939613 PMID:35439472
NCBI chr19:41,330,323...41,353,922
Ensembl chr19:41,301,587...41,353,922
G
TGFB2
transforming growth factor beta 2
decreases expression
EXP
obeticholic acid results in decreased expression of TGFB2 mRNA
CTD
PMID:27939613
NCBI chr 1:218,345,336...218,444,619
Ensembl chr 1:218,345,336...218,444,619
G
TGFB3
transforming growth factor beta 3
increases expression
EXP
obeticholic acid results in increased expression of TGFB3 mRNA
CTD
PMID:27939613
NCBI chr14:75,958,097...75,983,011
Ensembl chr14:75,958,097...75,983,011
G
TGFBR1
transforming growth factor beta receptor 1
decreases expression
EXP
obeticholic acid results in decreased expression of TGFBR1 mRNA
CTD
PMID:27939613
NCBI chr 9:99,103,647...99,154,192
Ensembl chr 9:99,104,038...99,154,192
G
TIMP1
TIMP metallopeptidase inhibitor 1
multiple interactions decreases expression
ISO EXP
NR0B2 protein affects the reaction [obeticholic acid inhibits the reaction [JUND protein binds to TIMP1 promoter]]; NR0B2 protein affects the reaction [obeticholic acid results in decreased expression of and results in decreased secretion of TIMP1 protein]; obeticholic acid inhibits the reaction [Carbon Tetrachloride results in increased expression of TIMP1 mRNA]; obeticholic acid results in decreased expression of and results in decreased secretion of TIMP1 protein obeticholic acid results in decreased expression of TIMP1 mRNA
CTD
PMID:15860571 PMID:27939613
NCBI chr X:47,582,436...47,586,789
Ensembl chr X:47,582,408...47,586,789
G
TIMP2
TIMP metallopeptidase inhibitor 2
multiple interactions
ISO
obeticholic acid inhibits the reaction [Carbon Tetrachloride results in increased expression of TIMP2 mRNA]
CTD
PMID:15860571
NCBI chr17:78,852,977...78,925,387
Ensembl chr17:78,852,977...78,925,387
G
TJP1
tight junction protein 1
multiple interactions
ISO
obeticholic acid promotes the reaction [[Dietary Fats co-treated with Dextran Sulfate] results in increased expression of TJP1 protein]
CTD
PMID:35439472
NCBI chr15:29,699,367...29,969,049
Ensembl chr15:29,699,367...29,968,915
G
TK1
thymidine kinase 1
decreases expression
EXP
obeticholic acid results in decreased expression of TK1 mRNA
CTD
PMID:27939613
NCBI chr17:78,174,079...78,187,204
Ensembl chr17:78,174,091...78,187,233
G
TLR4
toll like receptor 4
multiple interactions
ISO
obeticholic acid inhibits the reaction [[Dietary Fats co-treated with Dextran Sulfate] results in increased expression of TLR4 protein]; obeticholic acid inhibits the reaction [Methamphetamine results in increased expression of TLR4 protein]
CTD
PMID:35439472 PMID:35688268 PMID:36720452
NCBI chr 9:117,704,403...117,724,735
Ensembl chr 9:117,704,175...117,724,735
G
TNF
tumor necrosis factor
multiple interactions decreases secretion
ISO EXP
NR1H4 gene mutant form inhibits the reaction [obeticholic acid inhibits the reaction [TNF results in increased expression of SELP mRNA]]; obeticholic acid inhibits the reaction [1-Naphthylisothiocyanate results in increased expression of TNF mRNA]; obeticholic acid inhibits the reaction [[Methionine deficiency co-treated with Choline deficiency] results in increased expression of TNF protein]; obeticholic acid inhibits the reaction [Carbon Tetrachloride results in increased expression of TNF mRNA]; obeticholic acid inhibits the reaction [Dietary Fats results in increased expression of TNF protein]; obeticholic acid inhibits the reaction [Methamphetamine results in increased expression of TNF mRNA]; obeticholic acid inhibits the reaction [TNF results in increased expression of SELP mRNA] Obeticholic acid inhibits the reaction [ethanol increases expression of Tnf protein in liver] obeticholic acid results in decreased secretion of TNF protein obeticholic acid inhibits the reaction [Lipopolysaccharides results in increased secretion of TNF protein]
CTD RGD
PMID:21242261 PMID:22135065 PMID:27865854 PMID:29660435 PMID:30745416 PMID:35688268 PMID:36720452 PMID:38103844 PMID:27939985 More...
RGD:15036816
NCBI chr 6:31,575,565...31,578,336
Ensembl chr 6:31,575,565...31,578,336
G
TNFRSF1B
TNF receptor superfamily member 1B
increases expression
EXP
obeticholic acid results in increased expression of TNFRSF1B mRNA
CTD
PMID:27939613
NCBI chr 1:12,166,991...12,209,220
Ensembl chr 1:12,166,991...12,209,228
G
TRAF2
TNF receptor associated factor 2
decreases expression
EXP
obeticholic acid results in decreased expression of TRAF2 mRNA
CTD
PMID:27939613
NCBI chr 9:136,881,958...136,926,607
Ensembl chr 9:136,881,912...136,926,607
G
TXN
thioredoxin
decreases expression
EXP
obeticholic acid results in decreased expression of TXN mRNA
CTD
PMID:27939613
NCBI chr 9:110,243,810...110,256,507
Ensembl chr 9:110,243,810...110,256,507
G
TXNRD2
thioredoxin reductase 2
decreases expression
EXP
obeticholic acid results in decreased expression of TXNRD2 mRNA
CTD
PMID:27939613
NCBI chr22:19,875,522...19,941,818
Ensembl chr22:19,875,517...19,941,820
G
TYK2
tyrosine kinase 2
decreases expression
EXP
obeticholic acid results in decreased expression of TYK2 mRNA
CTD
PMID:27939613
NCBI chr19:10,350,533...10,380,572
Ensembl chr19:10,350,533...10,380,608
G
TYMP
thymidine phosphorylase
decreases expression
EXP
obeticholic acid results in decreased expression of TYMP mRNA
CTD
PMID:27939613
NCBI chr22:50,525,752...50,530,085
Ensembl chr22:50,525,752...50,530,032
G
UBE2E3
ubiquitin conjugating enzyme E2 E3
increases expression
EXP
obeticholic acid results in increased expression of UBE2E3 mRNA
CTD
PMID:27939613
NCBI chr 2:180,980,360...181,063,425
Ensembl chr 2:180,967,248...181,076,585
G
UBXN10
UBX domain protein 10
increases expression
EXP
obeticholic acid results in increased expression of UBXN10 mRNA
CTD
PMID:27939613
NCBI chr 1:20,183,331...20,196,050
Ensembl chr 1:20,186,096...20,196,050
G
UCKL1
uridine-cytidine kinase 1 like 1
decreases expression
EXP
obeticholic acid results in decreased expression of UCKL1 mRNA
CTD
PMID:27939613
NCBI chr20:63,939,829...63,956,416
Ensembl chr20:63,939,829...63,956,416
G
UGP2
UDP-glucose pyrophosphorylase 2
increases expression
EXP
obeticholic acid results in increased expression of UGP2 mRNA
CTD
PMID:27939613
NCBI chr 2:63,840,969...63,891,560
Ensembl chr 2:63,840,952...63,891,562
G
UGT1A1
UDP glucuronosyltransferase family 1 member A1
increases expression increases glucuronidation
EXP
obeticholic acid results in increased expression of UGT1A1 mRNA UGT1A1 protein results in increased glucuronidation of obeticholic acid
CTD
PMID:27939613 PMID:31299240
NCBI chr 2:233,760,270...233,773,300
Ensembl chr 2:233,760,270...233,773,300
G
UGT1A3
UDP glucuronosyltransferase family 1 member A3
multiple interactions increases glucuronidation
EXP
[Lapatinib results in decreased activity of UGT1A3 protein] which results in decreased glucuronidation of obeticholic acid UGT1A3 protein results in increased glucuronidation of obeticholic acid
CTD
PMID:31299240
NCBI chr 2:233,729,042...233,773,300
Ensembl chr 2:233,729,042...233,773,300
G
UGT1A4
UDP glucuronosyltransferase family 1 member A4
decreases expression increases glucuronidation
EXP
obeticholic acid results in decreased expression of UGT1A4 mRNA UGT1A4 protein results in increased glucuronidation of obeticholic acid
CTD
PMID:27939613 PMID:31299240
NCBI chr 2:233,718,736...233,773,300
Ensembl chr 2:233,718,736...233,773,300
G
UGT1A6
UDP glucuronosyltransferase family 1 member A6
decreases expression
EXP
obeticholic acid results in decreased expression of UGT1A6 mRNA
CTD
PMID:27939613
NCBI chr 2:233,691,702...233,773,300
Ensembl chr 2:233,691,607...233,773,300
G
UGT1A7
UDP glucuronosyltransferase family 1 member A7
decreases expression
EXP
obeticholic acid results in decreased expression of UGT1A7 mRNA
CTD
PMID:27939613
NCBI chr 2:233,681,901...233,773,300
Ensembl chr 2:233,681,901...233,773,300
G
UGT1A9
UDP glucuronosyltransferase family 1 member A9
decreases expression
EXP
obeticholic acid results in decreased expression of UGT1A9 mRNA
CTD
PMID:27939613
NCBI chr 2:233,671,898...233,773,300
Ensembl chr 2:233,671,898...233,773,300
G
UGT2B10
UDP glucuronosyltransferase family 2 member B10
increases expression
EXP
obeticholic acid results in increased expression of UGT2B10 mRNA
CTD
PMID:27939613
NCBI chr 4:68,815,994...68,832,023
Ensembl chr 4:68,815,994...68,832,023
G
UGT2B11
UDP glucuronosyltransferase family 2 member B11
increases expression
EXP
obeticholic acid results in increased expression of UGT2B11 mRNA
CTD
PMID:27939613
NCBI chr 4:69,199,951...69,224,984
Ensembl chr 4:69,199,951...69,214,748
G
UGT2B15
UDP glucuronosyltransferase family 2 member B15
increases expression
EXP
obeticholic acid results in increased expression of UGT2B15 mRNA
CTD
PMID:27939613
NCBI chr 4:68,646,597...68,670,652
Ensembl chr 4:68,646,597...68,670,652
G
UGT2B7
UDP glucuronosyltransferase family 2 member B7
decreases expression
EXP
obeticholic acid results in decreased expression of UGT2B7 mRNA
CTD
PMID:27939613
NCBI chr 4:69,051,375...69,112,987
Ensembl chr 4:69,051,363...69,112,987
G
UPB1
beta-ureidopropionase 1
decreases expression
EXP
obeticholic acid results in decreased expression of UPB1 mRNA
CTD
PMID:27939613
NCBI chr22:24,495,332...24,528,390
Ensembl chr22:24,494,107...24,528,390
G
UPP1
uridine phosphorylase 1
increases expression
EXP
obeticholic acid results in increased expression of UPP1 mRNA
CTD
PMID:27939613
NCBI chr 7:48,088,704...48,108,736
Ensembl chr 7:48,088,628...48,108,736
G
UPP2
uridine phosphorylase 2
increases expression
EXP
obeticholic acid results in increased expression of UPP2 mRNA
CTD
PMID:27939613
NCBI chr 2:157,995,179...158,136,154
Ensembl chr 2:157,876,679...158,136,154
G
UROC1
urocanate hydratase 1
increases expression
EXP
obeticholic acid results in increased expression of UROC1 mRNA
CTD
PMID:27939613
NCBI chr 3:126,481,166...126,517,773
Ensembl chr 3:126,481,166...126,517,773
G
XDH
xanthine dehydrogenase
increases expression
EXP
obeticholic acid results in increased expression of XDH mRNA
CTD
PMID:27939613
NCBI chr 2:31,334,321...31,414,742
Ensembl chr 2:31,334,321...31,414,742
Term paths to the root one shortest all shortest one longest all longest one shortest and longest all